<SEC-DOCUMENT>0001641172-25-019503.txt : 20250714
<SEC-HEADER>0001641172-25-019503.hdr.sgml : 20250714
<ACCEPTANCE-DATETIME>20250714160859
ACCESSION NUMBER:		0001641172-25-019503
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250711
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250714
DATE AS OF CHANGE:		20250714

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viewbix Inc.
		CENTRAL INDEX KEY:			0000797542
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		EIN:				680080601
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42681
		FILM NUMBER:		251121823

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		3 HANEHOSHET ST, BUILDING B
		STREET 2:		7TH FLOOR
		CITY:			TEL AVIV
		PROVINCE COUNTRY:   	L3
		ZIP:			6971068
		BUSINESS PHONE:		855-879-8439

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		3 HANEHOSHET ST, BUILDING B
		STREET 2:		7TH FLOOR
		CITY:			TEL AVIV
		PROVINCE COUNTRY:   	L3
		ZIP:			6971068

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Virtual Crypto Technologies, Inc.
		DATE OF NAME CHANGE:	20180312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Emerald Medical Applications Corp.
		DATE OF NAME CHANGE:	20151006

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZAXIS INTERNATIONAL INC
		DATE OF NAME CHANGE:	19950916
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:VBIX="http://view-bix.com/20250711">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_VBIX_view%2Dbix.com_20250711 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20250711_20250711 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0000797542 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-07-11" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-07-11" id="Fact000004" name="dei:EntityCentralIndexKey">0000797542</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="vbix-20250711.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-07-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-07-11</xbrli:startDate>
        <xbrli:endDate>2025-07-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90E_edei--DocumentType_c20250711__20250711_z8Z8u8s0Ro02"><ix:nonNumeric contextRef="AsOf2025-07-11" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of report (date of earliest event reported): <span id="xdx_904_edei--DocumentPeriodEndDate_c20250711__20250711_z0QZs7Fp7d7g"><ix:nonNumeric contextRef="AsOf2025-07-11" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">July 11, 2025</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_905_edei--EntityRegistrantName_c20250711__20250711_zoiwPH76ekAj"><ix:nonNumeric contextRef="AsOf2025-07-11" id="Fact000011" name="dei:EntityRegistrantName">VIEWBIX
INC.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in its Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
File No.: <span id="xdx_903_edei--EntityFileNumber_c20250711__20250711_zsZ3eyUqk1fh"><ix:nonNumeric contextRef="AsOf2025-07-11" id="Fact000012" name="dei:EntityFileNumber">001-42681</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20250711__20250711_zVlSmVo1GRNk"><ix:nonNumeric contextRef="AsOf2025-07-11" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20250711__20250711_zFkZA6hhUGHc"><ix:nonNumeric contextRef="AsOf2025-07-11" id="Fact000014" name="dei:EntityTaxIdentificationNumber">68-0080601</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    of Incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--EntityAddressAddressLine1_c20250711__20250711_z1rgPfNWUlpi"><ix:nonNumeric contextRef="AsOf2025-07-11" id="Fact000015" name="dei:EntityAddressAddressLine1">3
    Hanehoshet St</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressAddressLine2_c20250711__20250711_zXECk7hkwxge"><ix:nonNumeric contextRef="AsOf2025-07-11" id="Fact000016" name="dei:EntityAddressAddressLine2">Building B, 7th floor</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressCityOrTown_c20250711__20250711_zeCAoPlA1ZTj"><ix:nonNumeric contextRef="AsOf2025-07-11" id="Fact000017" name="dei:EntityAddressCityOrTown">Tel Aviv</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressCountry_c20250711__20250711_zmEleFL5z5n9"><ix:nonNumeric contextRef="AsOf2025-07-11" format="ixt-sec:countrynameen" id="Fact000018" name="dei:EntityAddressCountry">Israel</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--EntityAddressPostalZipCode_c20250711__20250711_zqWiButfA347"><ix:nonNumeric contextRef="AsOf2025-07-11" id="Fact000019" name="dei:EntityAddressPostalZipCode">6971068</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of Registrant&#8217;s Office)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ZIP
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
Telephone Number, including area code: <span id="xdx_90C_edei--CityAreaCode_c20250711__20250711_zayeMuwKWZDb"><ix:nonNumeric contextRef="AsOf2025-07-11" id="Fact000020" name="dei:CityAreaCode">+972</ix:nonNumeric></span> <span id="xdx_90D_edei--LocalPhoneNumber_c20250711__20250711_zSotMoRnKGFc"><ix:nonNumeric contextRef="AsOf2025-07-11" id="Fact000021" name="dei:LocalPhoneNumber">9-774-1505</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--WrittenCommunications_c20250711__20250711_zFEPmaxc2xnf"><ix:nonNumeric contextRef="AsOf2025-07-11" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--SolicitingMaterial_c20250711__20250711_z2EmdGtsyAXc"><ix:nonNumeric contextRef="AsOf2025-07-11" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementTenderOffer_c20250711__20250711_z9c7dPPEVxhl"><ix:nonNumeric contextRef="AsOf2025-07-11" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--PreCommencementIssuerTenderOffer_c20250711__20250711_zLEEvdikpTKd"><ix:nonNumeric contextRef="AsOf2025-07-11" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_902_edei--EntityEmergingGrowthCompany_c20250711__20250711_zoM6L4XmyHwf"><ix:nonNumeric contextRef="AsOf2025-07-11" format="ixt:booleanfalse" id="Fact000026" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    1.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entry
    into a Material Definitive Agreement.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="color: #212529">On
July 11, 2025, </span>Viewbix Inc. <span style="color: #212529">(the &#8220;Company&#8221;) entered into a securities purchase agreement
(the &#8220;Purchase Agreement&#8221;) with certain accredited investors pursuant to which the Company agreed to sell and issue in a private
placement (the &#8220;Private Placement Offering&#8221;) an aggregate of 848,763 shares (the &#8220;Private Placement Shares&#8221;) of
the Company&#8217;s common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;), pre-funded warrants (the &#8220;Pre-Funded
Warrants&#8221;) to purchase up to 77,160 shares of Common Stock and common warrants to purchase up to an aggregate of 925,923 shares
of Common Stock (the &#8220;Common Warrants&#8221; and together with the Pre-Funded Warrants, the &#8220;Warrants&#8221;), at an offering
price of $4.86 per Private Placement Share and associated Common Warrant and an offering price of $4.8599 per Pre-Funded Warrant and associated
Common Warrant.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pre-Funded Warrants will be immediately exercisable at an exercise price of $0.0001 per share and will not expire until exercised in
full. The Common Warrants will be immediately exercisable upon issuance at an exercise price of $4.74 per share, subject to adjustment
as set forth therein, and will expire five and a half years from the issuance date. The Common Warrants may be exercised on a cashless
basis if there is no effective registration statement registering the shares of Common Stock underlying the Common Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Purchase Agreement, the Company entered into a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;)
with each investor. Pursuant to the Registration Rights Agreement, the Company is required to file a resale registration statement (the
&#8220;Registration Statement&#8221;) with the Securities and Exchange Commission (the &#8220;SEC&#8221;) to register for resale the
Private Placement Shares and the shares of Common Stock issuable upon exercise of the Warrants within fourteen (14) trading days of the
signing date of the Purchase Agreement (the &#8220;Signing Date&#8221;), and to have such Registration Statement declared effective within
sixty (60) calendar days after the Signing Date in the event the Registration Statement is not reviewed by the SEC, or ninety (90) calendar
days of the Signing Date in the event the Registration Statement is reviewed by the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement and the Registration Rights Agreement contain representations, warranties, indemnification and other provisions customary
for transactions of this nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also entered into a letter agreement (the &#8220;Placement Agent Agreement&#8221;) with Aegis Capital Corp., as placement agent
(the &#8220;Placement Agent&#8221;), dated July 11, 2025, pursuant to which the Placement Agent agreed to serve as the placement agent
for in connection with the Private Placement Offering. The Company agreed to pay the Placement Agent a cash placement fee equal to 7.0%
of the gross proceeds received in the Private Placement Offering and $50,000 for reasonable legal fees and disbursements for the Placement
Agent&#8217;s counsel. In addition, pursuant to the Placement Agent Agreement, the Company agreed to abide by certain customary standstill
restrictions for a period of thirty (30) days following the later of the closing of the Private Placement Offering and the date that
the Registration Statement is declared effective by the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
gross proceeds to the Company in respect of the Private Placement Offering are expected to be approximately $4.5 million, before deducting
fees payable to the Placement Agent and other offering expenses payable by the Company. If the Warrants are exercised in cash in full
this would result in an additional $4.4 million of gross proceeds. The Private Placement Offering closed</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on July 14, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placement Shares, the Warrants to be issued in the Private Placement Offering and the shares of Common Stock underlying the Warrants
are being offered and sold pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of
1933, as amended (the &#8220;Securities Act&#8221;). The investors have represented that they are accredited investors, as that term
is defined in Regulation D, or qualified institutional buyers as defined in Rule 144(A)(a), and have acquired such securities for their
own account and have no arrangements or understandings for any distribution thereof. The offer and sale of the foregoing securities is
being made without any form of general solicitation or advertising. None of the Private Placement Shares, the Warrants to be issued in
the Private Placement Offering, nor the shares of Common Stock underlying the Warrants have been registered under the Securities Act
or applicable state securities laws. Accordingly, such securities may not be offered or sold in the United States except pursuant to
an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable
state securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Current Report on Form 8-K shall not constitute an offer to sell or the solicitation to buy nor shall there be any sale of the securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing descriptions of the Purchase Agreement, the Pre-Funded Warrants, the Common Warrants, the Registration Rights Agreement and
the Placement Agent Agreement are not complete, and are qualified in their entireties by reference to the full text of such documents,
copies of which are filed as Exhibits 10.1, 10.2, 10.3, 10.4 and 10.5, respectively, to this Current Report on Form 8-K and are incorporated
by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warning
Concerning Forward Looking Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Current Report on Form 8-K contains statements which constitute forward looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995 and other securities laws. These forward looking statements are based upon the Company&#8217;s present
intent, beliefs or expectations, but forward looking statements are not guaranteed to occur and may not occur for various reasons, including
some reasons which are beyond the Company&#8217;s control. For this reason, among others, you should not place undue reliance
upon the Company&#8217;s forward looking statements. Except as required by law, the Company undertakes no obligation to revise or update
any forward looking statements in order to reflect any event or circumstance that may arise after the date of this Current Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    3.02</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unregistered
    Sales of Equity Securities.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information under Item 1.01 of this Current Report on Form 8-K regarding the unregistered securities described herein is incorporated
herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    9.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
    Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Warrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex10-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Common Warrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex10-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Registration Rights Agreement</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex10-5.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Agreement</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Viewbix
    Inc.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Amihay Hadad</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amihay
    Hadad</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
July 14, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LXOdf7A7HTrEKTJEvC0uk+LWjLT+PZJvad0QQyAk53w5QgxERitdI8NpUeRwwKatlUMosEJGc0bvSNebBPws8KKtY2Vct/7AlDyDnpmGUvl757xri2UC0WwoR8N4ApFM4jHMtyL46imZSpdonFY1KFPCnqlljU7xq/9wUE8y1Ly6pCOy1WQSkGHUy2+IIxnDju7qQXy1kOepCAZdBSJjurXetXw6NF8SljU2Ps729L+DD8EBSko= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of July 11, 2025, between Viewbix Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns,
a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended
(the &ldquo;<U>Securities Act</U>&rdquo;), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser,
and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described
in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrants</U>&rdquo; means, collectively, the Common Stock purchase Warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Warrants shall be exercisable immediately upon issuance and have a term equal to five and one-half
(5.5) years, in the form of <U>Exhibit B-2</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Greenberg Traurig, P.A., One Azrieli Center, Round Tower, 30th floor, 132 Menachem Begin Rd, Tel Aviv 6701101
Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; means the earliest of the date that (a) the initial Registration Statement registering for resale all Shares and Warrant
Shares has been declared effective by the Commission, (b) all of the Shares and Warrant Shares have been sold pursuant to Rule 144 or
may be sold pursuant to Rule 144 without the requirement for the Company to be in compliance with the current public information required
under Rule 144 and without volume or manner-of-sale restrictions, (c) following the one year anniversary of the Closing Date provided
that a holder of Shares or Warrant Shares is not an Affiliate of the Company, or (d) all of the Shares and Warrant Shares may be sold
pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without volume or manner-of-sale restrictions
and Company Counsel has delivered to such holders a standing written unqualified opinion that resales may then be made by such holders
of the Shares and Warrant Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such
holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Escrow
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Company with offices at State Street, 30th Floor, New York, NY 10004.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Escrow
Agreement</U>&rdquo; means the escrow agreement entered into, by and among the Company, the Escrow Agent and the Placement Agent pursuant
to which the Purchasers shall deposit Subscription Amounts with the Escrow Agent to be applied to the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant
to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities
upon the exercise or exchange of or conversion of any Securities issued hereunder, warrants to the Placement Agent in connection with
the transactions pursuant to this Agreement and/or other securities exercisable or exchangeable for or convertible into shares of Common
Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this
Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities
(other than in connection with stock splits or combinations) or to extend the term of such securities, and (c) securities issued pursuant
to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided that such securities
are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the
filing of any registration statement in connection therewith, and provided that any such issuance shall only be to a Person (or to the
equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic
with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall
not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose
primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.1(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors, executive
officers, and the parties listed on Schedule 1.1, in the form of <U>Exhibit C</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $4.86 (less $0.0001 for each Pre-Funded Warrant), subject to adjustment for reverse and forward
stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means Aegis Capital Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means, collectively, the Pre-Funded Common Stock purchase warrants delivered to the Purchasers at the Closing in
accordance with Section 2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in
full, in the form of <U>Exhibit B-2</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Information Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Information Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Rights Agreement</U>&rdquo; means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers,
in the form of <U>Exhibit A</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering
the resale by the Purchasers of the Shares and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but excluding the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in; color: blue"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo;
in United States dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the OTCQB, OTCQX, Pink Open Market (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Registration Rights Agreement, the Lock-Up Agreement and all exhibits and
schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Transfer Online, the current transfer agent of the Company, with a mailing address of 512 SE Salmon Street, Portland,
OR 97214-3444, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Pre-Funded Warrants and the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASE
AND SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the
execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly,
agree to purchase, up to an aggregate of approximately $4.5 million of Shares and Warrants; provided, however, that, to the extent that
a Purchaser determines, in its sole discretion, that after giving effect to such purchase, the Purchaser (together with the Purchaser&rsquo;s
Affiliates, and any other Persons acting as a group together with the Purchaser or any of the Purchaser&rsquo;s Affiliates (such Persons,
&ldquo;Attribution Parties&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below, , in
lieu of purchasing Shares such Purchaser may elect to purchase Pre-Funded Warrants in lieu of Shares in such manner to result in the
same aggregate purchase price being paid by such Purchaser to the Company. Each Purchaser shall deliver to the Escrow Agent, via wire
transfer, immediately available funds equal to such Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed
by such Purchaser, and the Company shall deliver to each Purchaser its respective Shares and Warrants, as determined pursuant to Section
2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction
of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of the Placement Agent or such
other location as the parties shall mutually agree. For purposes hereof, beneficial ownership shall be calculated in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Purchaser that the
Company is not representing to the Purchaser that such calculation is in compliance with Section 13(d) of the Exchange Act and the Purchaser
is solely responsible for any schedules required to be filed in accordance therewith. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes hereof, in determining the number of outstanding shares of Common Stock, a Purchaser may rely on the number
of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission,
as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer
Agent setting forth the number of shares of Common Stock outstanding. In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of securities of the Company, including the Warrants, by the Purchaser
or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. Notwithstanding
anything to the contrary herein and the Purchaser&rsquo;s Subscription Amount set forth on the signature pages attached hereto, the number
of Shares purchased by a Purchaser (and its Affiliates and Attribution Parties) hereunder shall not, when aggregated with all other shares
of Common Stock beneficially owned by such Purchaser (and its Affiliates and Attribution Parties) at such time, result in such Purchaser
(and its Affiliates and Attribution Parties) beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act)
in excess of the Beneficial Ownership Limitation, and such Purchaser&rsquo;s Subscription Amount, to the extent it would otherwise exceed
the Beneficial Ownership Limitation immediately prior to the Closing, shall be conditioned upon the issuance of Shares at the Closing
to the other Purchasers signatory hereto. To the extent that a Purchaser&rsquo;s beneficial ownership of the Shares would otherwise be
deemed to exceed the Beneficial Ownership Limitation, such Purchasers&rsquo; Subscription Amount shall automatically be reduced as necessary
in order to comply with this paragraph. The &ldquo;Beneficial Ownership Limitation&rdquo; shall be 4.99% (or at the election of Purchaser,
9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities on the
Closing Date, including shares of Common Stock issuable upon exercise of the Warrants, provided that the Beneficial Ownership Limitation
in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of
such Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a legal opinion of Company Counsel, in a form reasonably acceptable to the Placement Agent and Purchasers;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate
evidencing a number of Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered
in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded
Warrant divided by the Per Share Purchase Price, with an exercise price equal to $0.0001, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
a Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of such
Purchaser&rsquo;s Shares, with an exercise price equal to $4.74, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
the Lock-Up Agreements; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
the Registration Rights Agreement duly executed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company or the Escrow Agent, as applicable,
the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
to the Company, this Agreement duly executed by such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
to the Escrow Agent, such Purchaser&rsquo;s Subscription Amount by wire transfer to the account specified in the Escrow Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
to the Company, the Registration Rights Agreement duly executed by such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a
specific date therein in which case they shall be accurate in all material respects (or, to the extent representations or warranties
are qualified by materiality, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein in which case they shall be accurate in all material respects or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall
be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the
corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth in <U>Schedule 3.1(a)</U>. The Company
owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and
all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and
free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references
to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material
Adverse Effect</U>&rdquo;); provided, however, that &ldquo;<U>Material Adverse Effect</U>&rdquo; shall not include any event, occurrence,
fact, condition or change, directly or indirectly, arising out of or attributable to: (i) the announcement, pendency or completion of
the transactions contemplated by the Transaction Documents, or (ii) any action required or permitted by the Transaction Documents or
any action taken (or omitted to be taken) with the written consent of or at the written request of Purchaser). As to all Company and
Subsidiary power, authority and qualification, no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing
or seeking to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith
other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission pursuant to the Registration Rights Agreement,
(iii) the notice and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing
of the Shares and Warrant Shares for trading thereon in the time and manner required thereby and (iv) the filing of Form D with the Commission
and such filings as are required to be made under applicable state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents. The Warrant Shares, when issued in accordance with the
terms of the Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the
Company other than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized
capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)(i)</U>, which <U>Schedule
3.1(g)(i)</U> shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company
as of the date hereof. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange
Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares
of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise
of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has
any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated
by the Transaction Documents. Except as set forth in <U>Schedule 3.1(g)(ii)</U> or as a result of the purchase and sale of the Securities,
there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to,
or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe
for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents
or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue
shares of Common Stock or other securities to any Person (other than the Purchasers). There are no outstanding securities or instruments
of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or
instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments of the
Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary.
The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement.
All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have
been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of
any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder,
the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting
agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge
of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein
as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has filed any
such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material
respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer
subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at
the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles
applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly
present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof
and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial,
year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development that has
had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on <U>Schedule 3.1(i)</U>, no
event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with
respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition
that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed
made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Litigation</U>. Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding
or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their
respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state,
county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U> (i)
adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii)
could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company
nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or
liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of
the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former
director or officer of the Company, except for routine examinations or investigations conducted by the Commission in the ordinary course
of business that would not have a Material Adverse Effect. The Commission has not issued any stop order or other order suspending the
effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be
expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or
toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which
the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None
of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights
has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date
of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included
within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe
upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge
of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any
of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy,
confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company
nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase
in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Transactions with Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, during the past three fiscal years
and the subsequent interim period through the date of this Agreement, none of the officers or directors of the Company or any Subsidiary
and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction
with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement
or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from,
providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or
such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance in all material respects with
any and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof, and any
and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of
the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable
assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information
required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized
and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have
evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period
covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The
Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation
Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the
Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial
reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Certain Fees</U>. Except for the fees and expenses of the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are
or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no
obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated
in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Private Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no
registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated
hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Registration Rights</U>. Other than to each of the Purchasers pursuant to the Registration Rights Agreement or as set forth in the
SEC Reports, no Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any
securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which
the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance
requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue
to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer
through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to
the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of
the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that it believes constitutes or might constitute material, non-public information. The Company understands
and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All
of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective
businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does
not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made
therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company
during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of
the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes
or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set
forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any
such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of
the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date. <U>Schedule 3.1(bb)</U> sets forth as of the date hereof all outstanding
secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For
the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess
of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other
contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection
or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due
under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to
any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Tax Status</U>. Except as set forth in <U>Schedule 3.1(cc)</U>, the Company and its Subsidiaries each (i) has made or filed all United
States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction
to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or
determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for
the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are
no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
or of any Subsidiary know of no basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>No General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and
certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Foreign Corrupt Practices.</U> Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA or any applicable
anti-corruption or anti-bribery laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Accountants</U>. The Company&rsquo;s accounting firm is set forth in the SEC Reports. To the knowledge and belief of the Company,
such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with
respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ended December 31, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>No Disagreements with Accountants and Lawyers.</U> There are no disagreements of any kind presently existing, or reasonably anticipated
by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company
is current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any
of its obligations under any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<FONT STYLE="text-decoration-style: double">Acknowledgment Regarding Purchaser&rsquo;s Trading Activity. Anything in this Agreement or
elsewhere herein to the contrary notwithstanding (except for Sections 3.2(g) and 4.14 hereof), it is understood and acknowledged by the
Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing
or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company
or to hold the Securities for any specified term, (ii) past or future open market or other transactions by any Purchaser, specifically
including, without limitation, Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private
placement transactions, may negatively impact the market price of the Company&rsquo;s publicly-traded securities, (iii) any Purchaser,
and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser is a party, directly or indirectly, presently
may have a &ldquo;short&rdquo; position in the Common Stock and (iv) each Purchaser shall not be deemed to have any affiliation with
or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction. </FONT>The Company further understands
and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during the period that the Securities
are outstanding, including, without limitation, during the periods that the value of the Warrant Shares deliverable with respect to Securities
are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders&rsquo; equity interests
in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned
hedging activities do not constitute a breach of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Regulation M Compliance.</U> The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company&rsquo;s placement agent in connection
with the placement of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or
prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
<U>No Disqualification Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the
Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of
the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity
securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act)
connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer
Covered Persons</U>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii)
under the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the
Purchasers a copy of any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)
<U>Other Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person)
that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)
<U>Notice of Disqualification Events</U>. The Company will notify the Purchasers and the Placement Agent in writing prior to the Closing
Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time,
reasonably be expected to become a Disqualification Event relating to any Issuer Covered Person, in each case of which it is aware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case
they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Own Account</U>. Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered
under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and
not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable
state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable
state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the
distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with
applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2),
(a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as defined in Rule 144A(a) under
the Securities Act. Such Purchaser hereby represents that neither such Purchaser nor any of its Rule 506(d) Related Parties (as defined
below) is a &ldquo;bad actor&rdquo; within the meaning of Rule 506(d) promulgated under the Securities Act. For purposes of this Agreement,
&ldquo;Rule 506(d) Related Party&rdquo; shall mean a person or entity covered by the &ldquo;Bad Actor disqualification&rdquo; provision
of Rule 506(d) of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>General Solicitation</U>. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other
communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or
presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither
the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect
to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be and has not been provided to it. In connection with the
issuance of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor
or fiduciary to such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER
AGREEMENTS OF THE PARTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Transfer Restrictions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection
with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion
of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the
Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and
the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration
Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in substantially
the following form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[NEITHER]
THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE] [HAS BEEN] REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY [AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY
SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer
pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,
including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of
any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act
to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Certificates evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b)
hereof), (i) while a registration statement (including the Registration Statement) covering the resale of such security is effective
under the Securities Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144 and the Company is then in compliance
with the current public information required under Rule 144 (assuming cashless exercise of the Warrants), (iii) if such Shares or Warrant
Shares are eligible for sale under Rule 144 (assuming cashless exercise of the Warrants), without the requirement for the Company to
be in compliance with the current public information required under Rule 144 as to such Shares and/or Warrant Shares and without volume
or manner-of-sale restrictions, or (iv) if such legend is not required under applicable requirements of the Securities Act (including
judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel to issue a legal
opinion to the Transfer Agent or the Purchaser promptly after the Effective Date if required by the Transfer Agent to effect the removal
of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion of a Warrant is exercised at a time when
there is an effective registration statement to cover the resale of the Warrant Shares, or if such Warrant Shares may be sold under Rule
144 (assuming cashless exercise of the Warrants) or if such legend is not otherwise required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Warrant Shares shall be issued
free of all legends. The Company shall cause its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective
Date if required by the Transfer Agent to effect the removal of the legend hereunder or if required by a Purchaser. The Company agrees
that following the Effective Date or at such time as such legend is no longer required under this Section 4.1(c), it will, no later than
the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below)
following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Shares or Warrant Shares, as
the case may be, issued with a restrictive legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered
to such Purchaser a certificate representing such shares that is free from all restrictive and other legends. The Company may not make
any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section
4. Certificates for Securities subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting
the account of the Purchaser&rsquo;s prime broker with the Depository Trust Company System as directed by such Purchaser. As used herein,
&ldquo;Standard Settlement Period&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Shares or
Warrants Shares, as the case may be, issued with a restrictive legend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
In addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day
(increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend
Removal Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to
be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such
Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an
open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion
of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of
shares of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive legend, then, an amount equal
to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any)
for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<U>Buy-In
Price</U>&rdquo;) over the product of (A) such number of Shares or Warrant Shares that the Company was required to deliver to such Purchaser
by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing
on the date of the delivery by such Purchaser to the Company of the applicable Shares or Warrant Shares (as the case may be) and ending
on the date of such delivery and payment under this clause (ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Each Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities
pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or
an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the
plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities
as set forth in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Furnishing of Information</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Until the earlier of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company covenants to maintain
the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect
thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to
the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would
require the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of
the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior
to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company
represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the
transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges
and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company,
any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the
Purchasers or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with each other
in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall
issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any
press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which
consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party
shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the
Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission
or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities
law in connection with (i) any registration statement contemplated by the Registration Rights Agreement and (ii) the filing of final
Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in
which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information
and agreed with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be
relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company delivers any
material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that
such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers,
directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall
remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder for general corporate purposes
and working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s debt (other
than (i) payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices and (ii) payment, in the
ordinary course of business, of amounts then currently due and payable on existing indebtedness owed to commercial banks), (b) for the
redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation
of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or
incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company
in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or
any of them or their respective Affiliates, by the Company or any stockholder of the Company who is not an Affiliate of such Purchaser
Party, arising out of or relating to any of the transactions contemplated by the Transaction Documents (unless such action is solely
based upon a material breach of such Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents
or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party
of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud,
gross negligence or willful misconduct). If any action shall be brought against any Purchaser Party in respect of which indemnity may
be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the
right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party
shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically
authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ
counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the
position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees
and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y)
for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld
or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s
breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other
Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount thereof during
the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein
shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities
the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep
available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company
to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Listing of Common Stock</U>. The Company hereby agrees to use its best efforts to maintain the listing or quotation of the Common
Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote
all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on
such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market,
it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause
all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then
take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all
respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company
agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established
clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established
clearing corporation in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Equal Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat
the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Reserved.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Reserved.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that
neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales, of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at
such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included
in the Disclosure Schedules. N<FONT STYLE="color: windowtext">otwithstanding the foregoing and notwithstanding anything contained in
this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty
or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no
Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable
securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to
the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade
in the securities of the Company to the Company or its Subsidiaries after the issuance of the initial press release as described in Section
4.4. </FONT>Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio
managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment
decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above shall
only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities
covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Form D; Blue Sky Filings</U>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16
<U>Reserved.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17
<U>Acknowledgment of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding
shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares pursuant
to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction,
regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive
effect that such issuance may have on the ownership of the other stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice
delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New
York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if
sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required
to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent
that any notice provided pursuant to any Transaction Document constitutes, or contains material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on
the initial Subscription Amounts hereunder (or, prior to the Closing Date, the Company and each Purchaser) or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver
disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser
(or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement of
this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner
impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the
rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior
written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon
each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>No Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties of
the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the
benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision
hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient
venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall
be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and
the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that
a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to
communicate with the Company through the legal counsel to the Placement Agent. The legal counsel of the Placement Agent does not represent
any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers with the same terms
and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers.
It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between
the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<U>Saturdays, Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21
<B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>viewbix inc.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line; width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amihay Hadad</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy to (which shall not constitute notice):</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Huberman, Esq. Greenberg Traurig, P.A.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One Azrieli Center</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Round Tower, 30th floor</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">132 Menachem Begin Rd</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel Aviv 6701101 Israel</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">VBIX</FONT> SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: ________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: __________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory: ______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Securities to Purchaser (if not same as address for notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount: $_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:
_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded
Warrants: __________________ Beneficial Ownership Blocker &#9744;  4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Warrants: __________________ Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: __________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex10-2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRE-FUNDED
COMMON STOCK PURCHASE WARRANT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIEWBIX
INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.95pt; vertical-align: middle; text-align: justify; width: 55%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: July 14, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: July 14, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [&#9679;] or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date set forth herein (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant
is exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Viewbix Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to [&#9679;] shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of the Company&rsquo;s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal
to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated July 11, 2025, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink- original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable, but
in no event later than three (3) Trading Days, following the date on which the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such
notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this
paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder
at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share,
was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the
nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise
of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise
price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to
the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment
hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo;
in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by
(A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
  applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise
  is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered
  pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(68)
  of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP on the Trading Day immediately
  preceding the date of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo;
  on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular
  trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise
  if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section
  2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 139.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 139.5pt; text-align: justify; text-indent: -31.5pt"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 139.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
  exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 139.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this
Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 143.95pt; text-align: justify; text-indent: -35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of- sale
limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered
in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. The Company agrees to
maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used
herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days,
on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of
Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 143.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: 26.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: 22.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: 22.95pt"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: 22.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy- In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 143.95pt; text-align: justify; text-indent: 23.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 143.95pt; text-align: justify; text-indent: 23.6pt"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 143.95pt; text-align: justify; text-indent: 23.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: 20.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in(A) the Company&rsquo;s most recent periodic or annual report filed with
the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company
or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the
Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which
such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99%
of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable
upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the
Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not
be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.95pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the
extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person (excluding mergers effected
solely to change the Company&rsquo;s name), (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding Common Stock, (iv) the
Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of
the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or
party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business
combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall
have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence
of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this
Warrant), and to the extent it is within the Company&rsquo;s control to cause the successor or acquiring corporation to deliver to the
Holder the foregoing, the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the
surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of
such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior
to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any
such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based
on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company
shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different
components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to
be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives
upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction that is within the Company&rsquo;s control and in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with
the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved
by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the
Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form
and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or
its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to
any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity),
and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the
other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.95pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.95pt; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.95pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 143.95pt; text-align: justify; text-indent: -35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: 29.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non- public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 143.95pt; text-align: justify; text-indent: 26.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 143.95pt; text-align: justify; text-indent: 26.3pt"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 143.95pt; text-align: justify; text-indent: 26.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof
and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation,
any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company
or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by
the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such
surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee
or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to
the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 71.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant
and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise,&rdquo; and to
receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the Company be required to net cash
settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 143.95pt; text-align: justify; text-indent: -35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 107.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 107.95pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 107.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand, and the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VIEWBIX
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amihay
                                            Hadad</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF EXERCISE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
<B>VIEWBIX INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ___________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7.15pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 115.15pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 115.15pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in
subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless
exercise procedure set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 115.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
___________________________________________________________________________________________</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
B</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5pt"></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _________________ ___, _________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: ________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:_________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex10-3.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMON
STOCK PURCHASE WARRANT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: -72.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: center; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIEWBIX
INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: -72.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
  Shares: [&#9679;]</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
  Date: July 14, 2025</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
  Exercise Date: July 14, 2025</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [*] or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date set forth herein (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on [&#9679;]
(the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Viewbix Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), up to [&#9679;] shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;)
of the Company&rsquo;s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated July 11, 2025, among the Company and the purchasers
signatory thereto and that certain Registration Rights Agreement dated July 11, 2025, among the Company and the purchasers signatory
thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink- original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable, but
in no event later than three (3) Trading Days, following the date on which the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such
notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this
paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder
at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be $4.74, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. The Company will use its best efforts to maintain an effective registration statement after the Effectiveness
Date of the Initial Registration Statement. If, after the six month anniversary of the Issue Date, at the time of exercise hereof there
is no effective registration statement registering, or the prospectus contained therein is not available for the resale of the Warrant
Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo;
in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by
(A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and
delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in
Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP on the Trading Day
immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading
hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular
trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise
if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section
2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this
Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of- sale
limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered
in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. The Company agrees to
maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used
herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days,
on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of
Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy- In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of
this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the
extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder
has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person (excluding mergers effected
solely to change the Company&rsquo;s name), (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding Common Stock, (iv) the
Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of
the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or
party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business
combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall
have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence
of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this
Warrant) and to the extent it is within the Company&rsquo;s control to cause the successor or acquiring corporation to deliver to the
Holder the foregoing, the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the
surviving corporation. The Company shall cause any successor entity in a Fundamental Transaction that is within the Company&rsquo;s control
and in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations
of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant
to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay)
prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and
be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction
Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power
of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the
same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non- public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board
of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof
and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation,
any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company
or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by
the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such
surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee
or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to
the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant
and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise,&rdquo; and to
receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the Company be required to net cash
settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand, and the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIEWBIX
    INC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amihay
    Hadad</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: -15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF EXERCISE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
<B>VIEWBIX INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase_________________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; width: 39%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; width: 39%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
___________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
                                            _____________________,_______________</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: ___________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: ____________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ex10-4.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REGISTRATION
RIGHTS AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Registration Rights Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of July 11, 2025, by and between Viewbix
Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each such purchaser,
a &ldquo;<U>Purchaser</U>&rdquo; and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser
(the &ldquo;<U>Purchase Agreement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and each Purchaser hereby agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Definitions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Capitalized
terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the
Purchase Agreement.</B> As used in this Agreement, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Initial Registration Statement required to be filed hereunder, the 60<SUP>th</SUP> calendar
day following the date hereof (or, in the event of a &ldquo;full review&rdquo; by the Commission, the 90<SUP>th</SUP> calendar day following
the date hereof) and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section
3(c), the 60<SUP>th</SUP> calendar day following the date on which an additional Registration Statement is required to be filed hereunder
(or, in the event of a &ldquo;full review&rdquo; by the Commission, the 90<SUP>th</SUP> calendar day following the date such additional
Registration Statement is required to be filed hereunder); <U>provided</U>, <U>however</U>, that in the event the Company is notified
by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to further review
and comments, the Effectiveness Date as to such Registration Statement shall be the fifth Trading Day following the date on which the
Company is so notified if such date precedes the dates otherwise required above, provided, further, if such Effectiveness Date falls
on a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Filing
Date</U>&rdquo; means, with respect to the Initial Registration Statement required hereunder, the fourteenth (14<SUP>th</SUP>) Trading
Day following the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c)
or Section 3(c), the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement
related to the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: left; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnifying
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Initial
Registration Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Plan
of Distribution</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the
Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the
offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to
the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference
in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a) all Shares, (b) all Warrant Shares then issued and issuable upon exercise
of the Warrants (assuming on such date the Warrants are exercised in full without regard to any exercise limitations therein) and (c)
any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect
to the foregoing; <U>provided, however</U>, that any such Registrable Securities shall cease to be Registrable Securities (and the Company
shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto) for
so long as (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the Commission
under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective Registration
Statement, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities become eligible
for resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 as set forth in
a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders (assuming
that such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which, such securities
were issued or are issuable, were at no time held by any Affiliate of the Company, and all Warrants are exercised by &ldquo;cashless
exercise&rdquo; as provided in Section 2(c) of each of the Warrants), as reasonably determined by the Company, upon the advice of counsel
to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration
statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such
registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in any such registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
415</U>&rdquo; means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Selling
Stockholder Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Guidance</U>&rdquo; means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements
or requests of the Commission staff and (ii) the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Shelf Registration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale
of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on
a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not
then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate
form in accordance herewith, subject to the provisions of Section 2(e)) and shall contain (unless otherwise directed by at least 85%
in interest of the Holders) substantially the &ldquo;<U>Plan of Distribution</U>&rdquo; attached hereto as <U>Annex A</U> and substantially
the &ldquo;<U>Selling Stockholder</U>&rdquo; section attached hereto as <U>Annex B</U>; <U>provided</U>, <U>however</U>, that no Holder
shall be required to be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s express prior written consent. Subject to the
terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed under this Agreement (including,
without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly as possible after the filing thereof,
but in any event no later than the applicable Effectiveness Date, and shall use its best efforts to keep such Registration Statement
continuously effective under the Securities Act until the date that all Registrable Securities covered by such Registration Statement
(i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant to
Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144,
as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer
Agent and the affected Holders (the &ldquo;<U>Effectiveness Period</U>&rdquo;). The Company shall telephonically request effectiveness
of a Registration Statement as of 5:00 p.m. (New York City time) on a Trading Day. The Company shall immediately notify the Holders via
e-mail of the effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness
with the Commission, which shall be the date requested for effectiveness of such Registration Statement. The Company shall, by 9:30 a.m.
(New York City time) on the Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission
as required by Rule 424.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable
Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration
statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments
to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted
to be registered by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary
offering, subject to the provisions of Section 2(e); with respect to filing on Form S-3 or other appropriate form; <U>provided</U>, <U>however</U>,
that prior to filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration
of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation
612.09.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding any other provision of this Agreement, if the Commission or any SEC Guidance sets forth a limitation on the number of
Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding
that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater portion of Registrable
Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of Registrable Securities
to be registered on such Registration Statement will be reduced as follows: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">a.</TD>
    <TD STYLE="text-align: justify">First, the Company shall reduce or eliminate any securities to be included other than Registrable Securities;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">b.</TD>
    <TD STYLE="text-align: justify">Second, the Company shall reduce Registrable Securities represented by Warrant Shares (applied, in the case that some Warrant may be
registered, to the Holders on a pro rata basis based on the total number of unregistered Warrant Shares held by such Holders); and</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">c.</TD>
    <TD STYLE="text-align: justify">Third, the Company shall reduce Registrable Securities represented by Shares (applied, in the case that some Shares may be registered,
to the Holders on a pro rata basis based on the total number of unregistered Shares held by such Holders).</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a cutback hereunder, the Company shall give the Holder at least two (2) Trading Days prior written notice along with the
calculations as to such Holder&rsquo;s allotment. In the event the Company amends the Initial Registration Statement in accordance with
the foregoing, the Company will use its best efforts to file with the Commission, as promptly as allowed by the Commission or SEC Guidance
provided to the Company or to registrants of securities in general, one or more registration statements on Form S-3 or such other form
available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement,
as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
[RESERVED.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
If Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the
resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3
as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect
until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate
of a Holder as any Underwriter without the prior written consent of such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Registration Procedures</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Company&rsquo;s registration obligations hereunder, the Company shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Not less than two (2) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to
the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed
to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed,
which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders,
and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall
be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning
of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto
to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is
notified of such objection in writing no later than two (2) Trading Days after the Holders have been so furnished copies of a Registration
Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements
thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as <U>Annex C</U>
(a &ldquo;<U>Selling Stockholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading Days from the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus
used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable
Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to
register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration
Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material
respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable
Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with
the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus
as so supplemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock
then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to
the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such
Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied
by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible
(and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm
such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective
amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to
a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or
any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings
for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding
for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement,
Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending
corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company,
makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus; <U>provided</U>,
<U>however</U>, that in no event shall any such notice contain any information which would constitute material, non-public information
regarding the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Use its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness
of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable
Securities for sale in any jurisdiction, at the earliest practicable moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Furnish to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested
by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference)
promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished in physical form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto
by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and
any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the Registration or qualification) of
such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United
States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during
the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions
of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable
Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted
by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered
in such names as any such Holder may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Upon the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into
account the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure
of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to
the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document
so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading. <FONT STYLE="text-decoration-style: double">If the Company notifies the Holders in accordance
with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus
have been made, then the Holders shall suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of
the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise its right under this Section 3(j)
to suspend the availability of a Registration Statement and Prospectus for a period not to exceed 60 calendar days (which need not be
consecutive days) in any 12-month period</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities
Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any
supplement or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing
if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
Reserved .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock
beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control
over the shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Registration Expenses</U>. All fees and expenses incident to the performance of or compliance with, this Agreement by the Company
shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses
referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation,
fees and expenses of the Company&rsquo;s counsel and independent registered public accountants) (A) with respect to filings made with
the Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for
trading, and (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including,
without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the
Registrable Securities), (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities),
(iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability
insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection
with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its
internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without
limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual
audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required
hereunder. In no event shall the Company be responsible for any broker or similar commissions of any Holder or, except to the extent
provided for in the Transaction Documents, any legal fees or other costs of the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Indemnification by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless
each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities
as principal as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees
(and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any
other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with
a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such
controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities,
costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as
incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement,
any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of
or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements
therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading
or (2) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any
rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but
only to the extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished in
writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such
Holder&rsquo;s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder
expressly for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto (it being understood that the
Holder has approved Annex A hereto for this purpose) or (ii) in the case of an occurrence of an event of the type specified in Section
3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such
Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt
by such Holder of the Advice contemplated in Section 6(d). The Company shall notify the Holders promptly of the institution, threat or
assertion of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is
aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified
person and shall survive the transfer of any Registrable Securities by any of the Holders in accordance with Section 6(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Indemnification by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors,
officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged
untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be
stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained
in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such
Prospectus or (ii) to the extent, but only to the extent, that such information relates to such Holder&rsquo;s information provided in
the Selling Stockholder Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly
approved in writing by such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex
A hereto for this purpose), such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder
be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating
to this Section 5 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or
omission) received by such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such
indemnification obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Conduct of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is
sought (the &ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve
the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be
finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure
shall have materially and adversely prejudiced the Indemnifying Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party
has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such
Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to
any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to
the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent
such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing
that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to
assume the defense thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying
Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which
consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified
Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to
the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section)
shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided
that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such
actions for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject
to appeal or further review) not to be entitled to indemnification hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Contribution</U>. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold
an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified
Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative
fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in
question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has
been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative
intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or
payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any
reasonable attorneys&rsquo; or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party
would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party
in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata
allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately
preceding paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the
dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the
amount of any damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission
or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have
to the Indemnified Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Remedies</U>. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement,
each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement,
including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and
each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it
of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect
of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>No Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Except as set forth on <U>Schedule 6(b)</U>
attached hereto, neither the Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include
securities of the Company in any Registration Statements other than the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
[RESERVED]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Discontinued Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from
the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue
disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will
use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Amendments and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified
or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing
and signed by the Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification,
this includes any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification
or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder
(or group of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities pursuant to
a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each
Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities
shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof
with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly
affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver
or consent relates; <U>provided</U>, <U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented
except in accordance with the provisions of the first sentence of this Section 6(f). No consideration shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered
to all of the parties to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered
as set forth in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Successors and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations
hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign
their respective rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>No Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the
Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities,
that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions
hereof. Except as set forth on <U>Schedule 6(i)</U>, neither the Company nor any of its Subsidiaries has previously entered into any
agreement granting any registration rights with respect to any of its securities to any Person that have not been satisfied in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Execution and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall
be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to
the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered
by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page
were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be
determined in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Cumulative Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Headings</U>. The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be
deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Independent Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint
with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations
of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action
taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture
or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity
with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges
that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations
or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out
of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such
purpose. The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company,
not the action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested
to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company
and a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Viewbix
    inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amihay
    Hadad</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGE OF HOLDERS FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: left; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
PAGE OF HOLDERS TO VBIX RRA]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Holder: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Holder</I>: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: left; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Plan
of Distribution</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Selling Stockholder (the &ldquo;<U>Selling Stockholders</U>&rdquo;) of the securities and any of their pledgees, assignees and successors-in-interest
may, from time to time, sell any or all of their securities covered hereby on the principal Trading Market or any other stock exchange,
market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices.
A Selling Stockholder may use any one or more of the following methods when selling securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block
    as principal to facilitate the transaction;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement
    of short sales; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated
    price per security;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933,
as amended (the &ldquo;<U>Securities Act</U>&rdquo;), if available, rather than under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: left; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in
excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal transaction a markup or
markdown in compliance with FINRA IM-2440.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they
assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan
or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option
or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the
delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company
has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under
the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders
without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for
the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar
effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule
of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable
state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered
or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is
complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously
engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M,
prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the
Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the
common stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders
and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annex
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLING
SHAREHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common stock being offered by the selling shareholders are those previously issued to the selling shareholders, and those issuable to
the selling shareholders, upon exercise of the warrants. For additional information regarding the issuances of those shares of common
stock and warrants, see &ldquo;Private Placement of Shares of Common Stock and Warrants&rdquo; above. We are registering the shares of
common stock in order to permit the selling shareholders to offer the shares for resale from time to time. Except for the ownership of
the shares of common stock and the warrants, the selling shareholders have not had any material relationship with us within the past
three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the selling shareholders and other information regarding the beneficial ownership of the shares of common stock by
each of the selling shareholders. The second column lists the number of shares of common stock beneficially owned by each selling shareholder,
based on its ownership of the shares of common stock and warrants, as of ________, 2025, assuming exercise of the warrants held by the
selling shareholders on that date, without regard to any limitations on exercises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
third column lists the shares of common stock being offered by this prospectus by the selling shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of a registration rights agreement with the selling shareholders, this prospectus generally covers the resale
of the sum of (i) the number of shares of common stock issued to the selling shareholders in the &ldquo;Private Placement of Shares of
Common Stock and Warrants&rdquo; described above and (ii) the maximum number of shares of common stock issuable upon exercise of the
related warrants, determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date
this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of
determination and all subject to adjustment as provided in the registration right agreement, without regard to any limitations on the
exercise of the warrants. The fourth column assumes the sale of all of the shares offered by the selling shareholders pursuant to this
prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the warrants, a selling shareholder may not exercise the warrants to the extent such exercise would cause such selling shareholder,
together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed 4.99%
of our then outstanding common stock following such exercise, excluding for purposes of such determination shares of common stock issuable
upon exercise of the warrants which have not been exercised. The number of shares in the second column does not reflect this limitation.
The selling shareholders may sell all, some or none of their shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: left; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of Selling<BR>
 Shareholder</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1pt; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of shares of<BR>
 Common Stock Owned<BR>
 Prior to Offering</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1pt; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum
    Number of shares<BR>
 of Common Stock to be Sold<BR>
 Pursuant to this Prospectus</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1pt; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of shares of<BR>
 Common Stock Owned <BR>
After Offering</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annex
C</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">VIEWBIX
INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
Stockholder Notice and Questionnaire</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned beneficial owner of common stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of Viewbix Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), understands that the Company has filed or intends to file with the Securities and Exchange Commission
(the &ldquo;<U>Commission</U>&rdquo;) a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) for the registration
and resale under Rule 415 of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Registrable Securities,
in accordance with the terms of the Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) to which this
document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth
below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly,
holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences
of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned beneficial owner (the &ldquo;<U>Selling Stockholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable
Securities owned by it in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: left; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUESTIONNAIRE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name.</B></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Legal Name of Selling Stockholder</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote
    or dispose of the securities covered by this Questionnaire):</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
Address for Notices to Selling Stockholder:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact
    Person:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Broker-Dealer Status:</B></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in">(a)</TD>
    <TD STYLE="text-align: justify">Are you a broker-dealer?</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; width: 49%">Yes &#9744;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 49%"> No &#9744;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.5in; vertical-align: top">(b)</TD>
    <TD STYLE="text-align: justify">If &ldquo;yes&rdquo; to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to
the Company?</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; width: 49%">Yes &#9744;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 49%">No &#9744;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.5in; vertical-align: top">Note:</TD>
    <TD STYLE="text-align: justify">If &ldquo;no&rdquo; to Section 3(b), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the
Registration Statement.</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.5in; vertical-align: top">(c)</TD>
    <TD>Are you an affiliate of a broker-dealer?</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; width: 49%">Yes &#9744;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 49%">No &#9744;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.5in; vertical-align: top">(d)</TD>
    <TD STYLE="text-align: justify">If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business,
and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly,
with any person to distribute the Registrable Securities?</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; width: 49%">Yes &#9744;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 49%">No &#9744;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.5in; vertical-align: top">Note:</TD>
    <TD>If &ldquo;no&rdquo; to Section 3(d), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the
Registration Statement.</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Beneficial Ownership of Securities of the Company Owned by the Selling Stockholder.</B></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Except
as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than
the securities issuable pursuant to the Purchase Agreement.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type and Amount of other securities beneficially owned by the
Selling Stockholder:</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">5. Relationships with the Company:</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Except
as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5%
of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with
the Company (or its predecessors or affiliates) during the past three years.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">State
any exceptions here:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees to promptly notify the Company of any material inaccuracies or changes in the information provided herein that may
occur subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall
not be required to notify the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and
the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto.
The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment
of the Registration Statement and the related prospectus and any amendments or supplements thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either
in person or by its duly authorized agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:______________________________    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial Owner: </FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;__________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLEASE
EMAIL A .PDF COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 24; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>ex10-5.htm
<DESCRIPTION>EX-10.5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.5</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-5_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
11, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>PERSONAL
AND CONFIDENTIAL</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Amihay Hadad, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viewbix
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
Hanehoshet St, Building B, 7th floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
Aviv, Israel 6971068</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>VBIX | PIPE Offering | Placement Agent Agreement</U></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Mr. Hadad:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of this Placement Agent Agreement is to outline our agreement pursuant to which Aegis Capital Corp. (&ldquo;<B><U>Aegis</U></B>&rdquo;)
will act as the placement agent on a &ldquo;best efforts&rdquo; basis in connection with the proposed PIPE Offering (the &ldquo;<B><U>Placement</U></B>&rdquo;)
by Viewbix Inc. (collectively, with its subsidiaries and affiliates, the &ldquo;<B><U>Company</U></B>&rdquo;) of its shares of Common
Stock (or Pre-funded Warrant (&ldquo;<B><U>Pre-funded Warrants</U></B>&rdquo;) in lieu thereof) and warrants (&ldquo;<B><U>Warrants</U></B>&rdquo;)
to purchase shares of Common Stock (collectively, the &ldquo;<B><U>Securities</U></B>&rdquo;). This Placement Agent Agreement sets forth
certain conditions and assumptions upon which the Placement is premised. The Company expressly acknowledges and agrees that Aegis&rsquo;s
obligations hereunder are on a reasonable &ldquo;best efforts&rdquo; basis only and that the execution of this Agreement does not constitute
a commitment by Aegis to purchase the Securities and does not ensure the successful placement of the Securities or any portion thereof
or the success of Aegis with respect to securing any other financing on behalf of the Company. The Company confirms that entry into this
Placement Agent Agreement and completion of the Placement with Aegis will not breach or otherwise violate the Company&rsquo;s obligations
to any other party or require any payments to such other party. For the sake of clarity, such obligations may include but not be limited
to obligations under an engagement letter, placement agency agreement, underwriting agreement, advisory agreement, right of first refusal,
tail fee obligation or other agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The terms of our agreement
are as follows:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Engagement</U></B>.
The Company hereby engages Aegis, for the period beginning on the date hereof and ending two (2) business days thereafter or upon the
completion of the Placement, whichever is sooner (the &ldquo;<B><U>Engagement Period</U></B>&rdquo;), to act as the Company&rsquo;s exclusive
placement agent and investment bank in connection with the proposed Placement. During the Engagement Period or until the consummation
of the Placement, and as long as Aegis is proceeding in good faith with preparations for the Placement, the Company agrees not to solicit,
negotiate with or enter into any agreement with any other source of financing (whether equity, debt or otherwise), any underwriter, potential
underwriter, placement agent, financial advisor, investment banking firm or any other person or entity in connection with an offering
of the Company&rsquo;s debt or equity securities or any other financing by the Company. Aegis will use its reasonable &ldquo;best efforts&rdquo;
to solicit offers to purchase the Securities from the Company on the terms, and subject to the conditions, set forth in the Prospectus
(as defined below). Aegis shall use commercially reasonable efforts to assist the Company in obtaining performance by each Purchaser
(as defined below) whose offer to purchase Securities has been solicited by Aegis, but Aegis shall not, except as otherwise provided
in this Agreement, be obligated to disclose the identity of any potential purchaser or have any liability to the Company in the event
any such purchase is not consummated for any reason. The Company acknowledges that under no circumstances will Aegis be obligated to
underwrite or purchase any Securities for its own account and, in soliciting purchases of the Securities, Aegis shall act solely as an
agent of the Company. The services provided pursuant to this Placement Agent Agreement shall be on an &ldquo;agency&rdquo; basis and
not on a &ldquo;principal&rdquo; basis.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1345
Avenue of the Americas &#183; New York, New York &#183; 10105</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(212)
813-1010 &#183; Fax (212) 813-1047 &#183; Member FINRA, SIPC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: left; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-5_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>The
Placement</U></B>. The Placement is expected to consist of a sale of approximately $4.0 million of the Company&rsquo;s Securities. The
Placement will be a private placement of units, with each unit consisting of one share of the Company&rsquo;s common stock and one Warrant,
each Warrant to purchase one share of the Company&rsquo;s common stock, or consisting of one Pre-Funded Warrant to purchase one share
of common stock and one Warrant. Aegis will act as placement agent for the Placement subject to, among other matters referred to herein
and additional customary conditions, completion of Aegis&rsquo;s due diligence examination of the Company and its affiliates, listing
approval by the Nasdaq Capital Market (&ldquo;<B><U>Exchange</U></B>&rdquo;) of the Securities to be issued, and the execution of a definitive
Securities Purchase Agreement in connection with the Placement (the &ldquo;<B><U>Securities Purchase Agreement</U></B>&rdquo;). The actual
size of the Placement, the precise number of Securities to be offered by the Company and the offering price will be the subject of continuing
negotiations between the Company and the investors thereto.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Placement
Compensation</U></B>. The placement commission will be 7.0% for the Placement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Registration
    Statement</U></B>. To the extent the Company decides to proceed with the Placement, the Company will, as soon as practicable and
    in no event later than the times set forth in the registration rights agreement to be entered into with the investors in the Placement,
    prepare and file with the Securities and Exchange Commission (the &ldquo;<B><U>Commission</U></B>&rdquo;) a Registration Statement
    on Form S-1 or Form S-3 (the &ldquo;<B><U>Registration Statement</U></B>&rdquo;) under the Securities Act of 1933, as amended (the
    &ldquo;<B><U>Securities Act</U></B>&rdquo;) and a prospectus included therein (the &ldquo;<B><U>Prospectus</U></B>&rdquo;) covering
    the resale of the Securities to be offered and sold in the Placement. The Registration Statement (including the Prospectus therein),
    and all amendments and supplements thereto, will be in form reasonably satisfactory to the investors, Aegis and counsel to the investors
    and Aegis. Other than any information provided by the investors or Aegis in writing specifically for inclusion in the Registration
    Statement or the Prospectus, the Company will be solely responsible for the contents of its Registration Statement and Prospectus
    and any and all other written or oral communications provided by or on behalf of the Company to any actual or prospective investor
    of the Securities, and the Company represents and warrants that such materials and such other communications will not, as of the
    date of each filing of the Registration Statement and any amendments or as of the date of effectiveness, contain any untrue statement
    of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein,
    in light of the circumstances under which they were made, not misleading. If at any time prior to the completion of the resale of
    the Securities by the investors an event occurs that would cause the Registration Statement or Prospectus (as supplemented or amended)
    to contain an untrue statement of a material fact or to omit to state a material fact necessary in order to make the statements therein,
    in light of the circumstances under which they were made, not misleading, the Company will notify Aegis and the investors immediately
    of such event and the Company shall prepare a supplement or amendment to the Registration Statement or Prospectus that corrects such
    statement or omission.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-5_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Lock-Ups</U></B>.
    In connection with the Placement, the Company&rsquo;s directors, executive officers, employees and shareholders holding at least
    ten percent (10%) of the outstanding common stock will enter into customary &ldquo;lock-up&rdquo; agreements in favor of the Placement
    Agent for a period of sixty (60) days after the later of the Closing of the Placement or effectiveness of the Registration Statement
    (the &ldquo;<B><U>Lock-Up Period</U></B>&rdquo;); provided, however, that any sales by parties to the lock-ups shall be subject to
    the lock-up agreements and provided further, that none of such common stock shall be saleable in the public market until the expiration
    of the Lock-Up Period.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Company
Standstill</U></B>. In connection with the Placement, without the prior written consent of the investors, the Company will not, for a
period of sixty (60) days after the later of the Closing of the Placement or effectiveness of the Registration Statement (the &ldquo;<B><U>Standstill
Period</U></B>&rdquo;), (a) offer, sell, issue, or otherwise transfer or dispose of, directly or indirectly, any equity of the Company
or any securities convertible into or exercisable or exchangeable for equity of the Company; (b) file or caused to be filed any registration
statement with the Commission relating to the offering of any equity of the Company or any securities convertible into or exercisable
or exchangeable for equity of the Company; or (c) enter into any agreement or announce the intention to effect any of the actions described
in subsections (a) or (b) hereof (all of such matters, the &ldquo;<B><U>Standstill Restrictions</U></B>&rdquo;). So long as none of such
equity securities shall be saleable in the public market until the expiration of the Standstill Period, the following matters shall not
be prohibited by the Standstill Restrictions: (i) the adoption of an equity incentive plan and the grant of awards or equity pursuant
to any equity incentive plan, and the filing of a registration statement on Form S-8; (ii) securities issued pursuant to agreements,
options, restricted share units or convertible securities existing as of the date hereof provided the terms are not modified; and (iii)
securities issued pursuant to acquisitions or strategic transactions (whether by merger, consolidation, purchase of equity, purchase
of assets, reorganization or otherwise) approved by a majority of the disinterested directors of the Company, provided that such securities
are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the
filing of any registration statement in connection therewith during the Standstill Period, and provided that any such issuance shall
only be to a person or entity (or to the equityholders of an entity) which is, itself or through its subsidiaries, an operating company
or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits
in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for
the purpose of raising capital or to an entity whose primary business is investing in securities. In no event should any equity transaction
during the Standstill Period result in the sale of equity at an offering price to the public less than that of the Placement referred
herein.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-5_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Expenses</U></B>.
The Company will be responsible for and will pay all expenses relating to the Placement, including, without limitation, (a) all filing
fees and expenses relating to the registration of the Securities with the Commission; (b) all FINRA Public Offering filing fees; (c)
all fees and expenses relating to the listing of the Company&rsquo;s equity or equity-linked securities on an Exchange; (d) all fees,
expenses and disbursements relating to the registration or qualification of the Securities under the &ldquo;blue sky&rdquo; securities
laws of such states and other jurisdictions as Aegis may reasonably designate (including, without limitation, all filing and registration
fees, and the reasonable fees and disbursements of the Company&rsquo;s &ldquo;blue sky&rdquo; counsel, which will be Aegis&rsquo;s counsel)
unless such filings are not required in connection with the Company&rsquo;s proposed Exchange listing; (e) all fees, expenses and disbursements
relating to the registration, qualification or exemption of the Securities under the securities laws of such foreign jurisdictions as
Aegis may reasonably designate; (f) the costs of all mailing and printing of the Placement documents; (g) transfer and/or stamp taxes,
if any, payable upon the transfer of Securities from the Company to Aegis; (h) the fees and expenses of the Company&rsquo;s accountants;
and (I) $50,000 for reasonable legal fees and disbursements for Aegis&rsquo;s counsel.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Termination</U></B>.
    Notwithstanding anything to the contrary contained herein, the Company agrees that the provisions relating to the payment of fees,
    reimbursement of expenses, indemnification and contribution, confidentiality, conflicts, independent contractor and waiver of the
    right to trial by jury will survive any termination or expiration of this Placement Agent Agreement. Notwithstanding anything to
    the contrary contained herein, the Company has the right to terminate this Agreement for cause in compliance with FINRA Rule 5110(g)(5)(B)(i).
    Notwithstanding anything to the contrary contained in this Agreement, in the event that no Placement is completed for any reason
    whatsoever during the Engagement Period, the Company shall be obligated to pay to Aegis its actual and accountable out-of-pocket
    expenses related to the Placement (including the fees and disbursements of Placement Agent&rsquo;s legal counsel) and if applicable,
    for electronic road show service used in connection with the Placement. During the engagement hereunder: (i) the Company will not,
    and will not permit its representatives to, other than in coordination with Aegis, contact or solicit institutions, corporations
    or other entities or individuals as potential purchasers of the Securities and (ii) the Company will not pursue any financing transaction
    which would be in lieu of the Placement. Furthermore, the Company agrees that during Aegis&rsquo;s engagement hereunder, all inquiries
    from prospective investors will be referred to Aegis.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-5_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Closing;
    Closing Deliverables</U></B>. Unless otherwise directed by the Placement Agent, settlement of the Securities shall occur via &ldquo;Delivery
    Versus Payment&rdquo; (&ldquo;<B><U>DVP</U></B>&rdquo;) (i.e., on the Closing Date, the Company shall cause the Depositary to issue
    the Securities directly to the clearing firm designated by the Placement Agent; upon receipt of such Securities, the Placement Agent
    shall promptly electronically deliver such Securities to the applicable Purchaser, and payment therefor shall be made by the
    Placement Agent (or its clearing firm) by wire transfer to the Company).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1. <B><U>Company
Deliveries</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.1.
On the date hereof, the Company shall deliver each of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.1.1
This Agreement duly executed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.1.2
A duly executed and delivered Officers&rsquo; Certificate, in customary form reasonably satisfactory to the Placement Agent and its counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.2.
On or prior to the Closing Date, the Company shall deliver each of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.2.1
A legal opinion of counsel to the Company, addressed to the Placement Agent and the Purchasers, in form and substance reasonably acceptable
to the Placement Agent and Purchasers.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.2.2
The Lock-Up Agreements.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.2.3
A copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate
(or at the request of the Purchaser, book entry statement) evidencing a number of shares of common stock equal to such Purchaser&rsquo;s
Subscription Amount (as defined in the Securities Purchase Agreement) divided by the Per Share Purchase Price (as defined in the Securities
Purchase Agreement), registered in the name of such Purchaser.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.2.4
For each Purchaser of Pre-Funded Warrants pursuant to Section 9, a Pre-Funded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded
Warrants divided by the Per Share Purchase Price, with an exercise price equal to $0.0001, subject to adjustment as provided therein.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.2.5
The Warrants, registered in the name of such Purchaser, to purchase up to a number of shares of Common Stock equal to the sum of 100.0%
of the number of shares of Common Stock and Pre-Funded Warrants stated on such Purchaser&rsquo;s signature page to the Securities Purchase
Agreement.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.2.6
The Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead and executed by the
Chief Executive Officer or Chief Financial Officer.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.2.7
A duly executed and delivered Officers&rsquo; Certificate, in customary form reasonably satisfactory to the Placement Agent and its counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-5_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Publicity</U></B>.
The Company agrees that it will not issue press releases or engage in any other publicity, without Aegis&rsquo;s prior written consent,
commencing on the date hereof and continuing until the final Closing of the Placement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Information</U></B>.
    During the Engagement Period or until the Closing, the Company agrees to cooperate with Aegis and to furnish, or cause to be furnished,
    to Aegis, any and all information and data concerning the Company, and the Placement that Aegis deems appropriate (the &ldquo;<B><U>Information</U></B>&rdquo;).
    The Company will provide Aegis reasonable access during normal business hours from and after the date of execution of this Placement
    Agent Agreement until the Closing to all of the Company&rsquo;s assets, properties, books, contracts, commitments and records and
    to the Company&rsquo;s officers, directors, employees, appraisers, independent accountants, legal counsel and other consultants and
    advisors. Except as contemplated by the terms hereof or as required by applicable law, Aegis will keep strictly confidential all
    non-public Information concerning the Company provided to Aegis. No obligation of confidentiality will apply to Information that:
    (a) is in the public domain as of the date hereof or hereafter enters the public domain without a breach by Aegis, (b) was known
    or became known by Aegis prior to the Company&rsquo;s disclosure thereof to Aegis as demonstrated by the existence of its written
    records, (c) becomes known to Aegis from a source other than the Company which information is not provided by the breach of an obligation
    of confidentiality owed to the Company, (d) is disclosed by the Company to a third party without restrictions on its disclosure or
    (e) is independently developed by Aegis as demonstrated by its written records. For the avoidance of doubt, except as otherwise provided
    herein, all information which is not publicly available relating to the Company&rsquo;s proprietary technology is proprietary and
    confidential.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>No
Third Party Beneficiaries; No Fiduciary Obligations</U></B>. This Placement Agent Agreement does not create, and shall not be construed
as creating, rights enforceable by any person or entity not a party hereto, except those entitled hereto by virtue of the indemnification
provisions hereof. The Company acknowledges and agrees that: (i) Aegis is not and shall not be construed as a fiduciary of the Company
and shall have no duties or liabilities to the equity holders or the creditors of the Company or any other person or entity by virtue
of this Placement Agent Agreement or the retention of Aegis hereunder, all of which are hereby expressly waived; and (ii) Aegis is a
full service securities firm engaged in a wide range of businesses and from time to time, in the ordinary course of its business, Aegis
or its affiliates may hold long or short positions and trade or otherwise effect transactions for its own account or the account of its
customers in debt or equity securities or loans of the companies which may be the subject of the transactions contemplated by this Placement
Agent Agreement. During the course of Aegis&rsquo;s engagement with the Company, Aegis may have in its possession material, non-public
information regarding other companies that could potentially be relevant to the Company or the transactions contemplated herein but which
cannot be shared due to an obligation of confidence to such other companies.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-5_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Indemnification,
Advancement &amp; Contribution</U></B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1. <B><U>Indemnification</U></B>.
The Company agrees to indemnify and hold harmless Aegis, its affiliates and each person controlling Aegis (within the meaning of
Section 15 of the Securities Act), and the directors, officers, agents and employees of Aegis, its affiliates and each such
controlling person (Aegis, and each such entity or person hereafter is referred to as an &ldquo;<B><U>Indemnified
Person</U></B>&rdquo;) from and against any losses, claims, damages, judgments, assessments, costs and other liabilities
(collectively, the &ldquo;<B><U>Liabilities</U></B>&rdquo;), and shall reimburse each Indemnified Person for all fees and expenses
(including the reasonable fees and expenses of counsel for the Indemnified Persons) (collectively, the
&ldquo;<B><U>Expenses</U></B>&rdquo;) and agrees to advance payment of such Expenses as they are incurred by an Indemnified Person
in investigating, preparing, pursuing or defending any actions, whether or not any Indemnified Person is a party thereto, arising
out of or based upon (i) any untrue statement or alleged untrue statement of a material fact contained in (A) the Registration
Statement, Prospectus or any other offering documents (as from time to time each may be amended and supplemented), (B) any materials
or information provided to investors by, or with the approval of, the Company in connection with the marketing of the Placement,
including any &ldquo;road show&rdquo; or investor presentations made to investors by the Company (whether in person or
electronically), or (C) any application or other document or written communication (collectively called &ldquo;application&rdquo;)
executed by the Company or based upon written information furnished by the Company in any jurisdiction in order to qualify the
Securities under the securities laws thereof or to file for an exemption from such requirement or filed with the Commission, any
state securities commission or agency, any national securities exchange; or (ii) the omission or alleged omission therefrom of a
material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading, unless such statement or omission was made in reliance upon, and in conformity with,
information provided to the Company by Aegis in writing specifically for use in the Registration Statement, Prospectus or any other
offering documents with respect which or resulting from conduct by Aegis or another Indemnified Party, as to which Aegis shall
indemnify and hold harmless the Company, its officers, directors and controlling parties in the manner set forth in this Section 13.
The Company also agrees to reimburse and advance each Indemnified Person for all Expenses as they are incurred in connection with
such Indemnified Person&rsquo;s enforcement of his or its rights under this Section 13.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2. <B><U>Procedure</U></B>.
Upon receipt by an Indemnified Person of actual notice of an action against such Indemnified Person with respect to which indemnity
may reasonably be expected to be sought under this Section 13, such Indemnified Person shall promptly notify the Company in writing;
provided that failure by any Indemnified Person so to notify the Company shall not relieve the Company from any obligation or
liability which the Company may have on account of this Section 13 or otherwise to such Indemnified Person. The Company shall, if
requested by Aegis, assume the defense of any such action (including the employment of counsel designated by Aegis and reasonably
satisfactory to the Company). Any Indemnified Person shall have the right to employ separate counsel in any such action and
participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person
unless: (i) the Company has failed promptly to assume the defense and employ separate counsel reasonably acceptable to Aegis for the
benefit of Aegis and the other Indemnified Persons or (ii) such Indemnified Person shall have been advised that in the opinion of
counsel that there is an actual or potential conflict of interest that prevents (or makes it imprudent for) the counsel designated
by and engaged by the Company for the purpose of representing the Indemnified Person, to represent both such Indemnified Person and
any other person represented or proposed to be represented by such counsel, in which event the Company shall pay the reasonable fees
and expenses of one counsel, plus local counsel, for all Indemnified Parties, which counsel shall, if Aegis is a defendant, be
designated by Aegis. The Company shall not be liable for any settlement of any action effected without its written consent (which
shall not be unreasonably withheld). In addition, the Company shall not, without the prior written consent of Aegis, settle,
compromise or consent to the entry of any judgment in or otherwise seek to terminate any pending or threatened action in respect of
which advancement, reimbursement, indemnification or contribution may be sought hereunder (whether or not such Indemnified Person is
a party thereto) unless such settlement, compromise, consent or termination (i) includes an unconditional release of each
Indemnified Person, acceptable to such Indemnified Party, from all Liabilities arising out of such action for which indemnification
or contribution may be sought hereunder and (ii) does not include a statement as to or an admission of fault, culpability or a
failure to act, by or on behalf of any Indemnified Person. The advancement, reimbursement, indemnification and contribution
obligations of the Company required hereby shall be made by periodic payments of the amount thereof during the course of the
investigation or defense, as every Liability and Expense is incurred and is due and payable, and in such amounts as fully satisfy
each and every Liability and Expense as it is incurred (and in no event later than 30 Calendar Days following the date of any
invoice therefore).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-5_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3. <B><U>Contribution</U></B>.
In the event that a court of competent jurisdiction makes a finding, final beyond right of review, that indemnity is unavailable to
an Indemnified Person, the Company shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in
such proportion as is appropriate to reflect (i) the relative benefits to the Company, on the one hand, and to Aegis and any other
Indemnified Person, on the other hand, of the matters contemplated by this Section 13 or (ii) if the allocation provided by the
immediately preceding clause is not permitted by applicable law, not only such relative benefits but also the relative fault of the
Company, on the one hand, and Aegis and any other Indemnified Person, on the other hand, in connection with the matters as to which
such Liabilities or Expenses relate, as well as any other relevant equitable considerations; provided that in no event shall the
Company contribute less than the amount necessary to ensure that all Indemnified Persons, in the aggregate, are not liable for any
Liabilities and Expenses in excess of the amount of commissions and non-accountable expense allowance actually received by Aegis in
the Placement. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the
Company on the one hand or Aegis on the other and the parties&rsquo; relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission. The Company and Aegis agree that it would not be just and equitable if
contributions pursuant to this subsection 13.3 were determined by pro rata allocation or by any other method of allocation which
does not take account of the equitable considerations referred to above in this subsection 13.3. For purposes of this paragraph, the
relative benefits to the Company, on the one hand, and to Aegis on the other hand, of the matters contemplated by this Section 13
shall be deemed to be in the same proportion as: (a) the total value received by the Company in the Placement, whether or not such
Placement is consummated, bears to (b) the commissions paid to Aegis under the Placement Agent Agreement. Notwithstanding the above,
no person guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the Securities Act shall be entitled to
contribution from a party who was not guilty of fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-5_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4. <B><U>Limitation</U></B>.
The Company also agrees that no Indemnified Person shall have any liability (whether direct or indirect, in contract or tort or
otherwise) to the Company for or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant
to this Placement Agent Agreement, the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in
connection with any such advice, services or transactions, except to the extent that a court of competent jurisdiction has made a
finding that Liabilities (and related Expenses) of the Company have resulted exclusively from such Indemnified Person&rsquo;s gross
negligence or willful misconduct in connection with any such advice, actions, inactions or services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <B><U>Equitable
    Remedies</U></B>. Each party to this Placement Agent Agreement acknowledges and agrees that (a) a breach or threatened breach by the
    Company of any of its obligations under the exclusivity provisions of Section 1 would give rise to irreparable harm to Aegis for
    which monetary damages would not be an adequate remedy and (b) if a breach or a threatened breach by the Company of any such
    obligations occurs, Aegis will, in addition to any and all other rights and remedies that may be available to such party at law, at
    equity, or otherwise in respect of such breach, be entitled to equitable relief, including a temporary restraining order, an
    injunction, specific performance of the terms of the exclusivity provisions of Section 1, as applicable, and any other relief that
    may be available from a court of competent jurisdiction, without any requirement to (i) post a bond or other security, or (ii) prove
    actual damages or that monetary damages will not afford an adequate remedy. Each party to this Placement Agent Agreement agrees that
    such party shall not oppose or otherwise challenge the existence of irreparable harm, the appropriateness of equitable relief or the
    entry by a court of competent jurisdiction of an order granting equitable relief, in either case, consistent with the terms of this
    Section 14.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Governing
Law; Venue</U></B>. This Placement Agent Agreement will be deemed to have been made and delivered in the State of New York, USA, and
both the binding provisions of this Placement Agent Agreement and the transactions contemplated hereby will be governed as to validity,
interpretation, construction, effect and in all other respects by the internal laws of the State of New York, without regard to the conflict
of laws principles thereof. Each of Aegis and the Company: (i) agrees that any legal suit, action or proceeding arising out of or relating
to this Placement Agent Agreement and/or the transactions contemplated hereby will be instituted exclusively in the courts located in
the Borough of Manhattan, City of New York, County of New York, State of New York (ii) waives any objection which it may have or hereafter
to the venue of any such suit, action or proceeding, and (iii) irrevocably consents to the jurisdiction of the courts located in the
City of New York, County of New York and State of New York, in any such suit, action or proceeding. Each of Aegis and the Company further
agrees to accept and acknowledge service of any and all process which may be served in any such suit, action or proceeding in such courts
and agrees that service of process upon the Company mailed by certified mail to the Company&rsquo;s address will be deemed in every respect
effective service of process upon the Company, in any such suit, action or proceeding, and service of process upon Aegis mailed by certified
mail to Aegis&rsquo;s address will be deemed in every respect effective service process upon Aegis, in any such suit, action or proceeding.
Notwithstanding any provision of this Placement Agent Agreement to the contrary, the Company agrees that neither Aegis nor its affiliates,
and the respective officers, directors, employees, agents and representatives of Aegis, its affiliates and each other person, if any,
controlling Aegis or any of its affiliates, will have any liability (whether direct or indirect, in contract or tort or otherwise) to
the Company for or in connection with the engagement and transaction described herein except for any such liability for losses, claims,
damages or liabilities incurred by the Company that are finally judicially determined to have resulted from the bad faith or gross negligence
of such individuals or entities. Aegis will act under this Placement Agent Agreement as an independent contractor with duties to the
Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Miscellaneous</U></B>.
The Company represents and warrants that it has all required power and authority to enter into and carry out the terms and provisions
of this Placement Agent Agreement and the execution, delivery and performance of this Placement Agent Agreement does not breach or conflict
with any agreement, document or instrument to which it is a party or bound. The binding provisions of this Placement Agent Agreement
are legally binding upon and inure to the benefit of both the Company and Aegis and their respective assigns, successors, and legal representatives.
If any provision of this Placement Agent Agreement is determined to be invalid or unenforceable in any respect, such determination will
not affect such provision in any other respect, and the remainder of the Placement Agent Agreement shall remain in full force and effect.
This Placement Agent Agreement may be executed in counterparts (including electronic counterparts), each of which shall be deemed an
original but all of which together shall constitute one and the same instrument. The undersigned hereby consents to receipt of this Placement
Agent Agreement in electronic form and understands and agrees that this Placement Agent Agreement may be signed electronically. Signatures
to this Placement Agent Agreement transmitted in electronic form will have the same effect as physical delivery of a paper document bearing
the original signature, and if any signature is delivered electronically evidencing an intent to sign this Placement Agent Agreement,
such electronic mail or other electronic transmission shall create a valid and binding obligation of the undersigned with the same force
and effect as if such signature were an original. Execution and delivery of this Placement Agent Agreement by electronic mail or other
electronic transmission is legal, valid and binding for all purposes.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Notices</U></B>.
All notices, consents, claims, demands, waivers, and other communications hereunder (&ldquo;<B><U>Notices</U></B>&rdquo;) shall be in
writing and sent by certified mail, hand delivery, overnight delivery or email, if sent to Aegis, at the address set forth on the first
page hereof, email: banking@aegis.com, and if sent to the Company, to the address set forth on the first page hereof, email: amihay@gix-internet.com,
attention: Amihay Hadad, Chief Executive Officer. All Notices shall be deemed to have been effectively given (a) when delivered by hand
(with written confirmation of receipt); (b) when received by the addressee if sent by FedEx or another nationally recognized overnight
courier (receipt requested); (c) on the date sent by email (with confirmation of receipt from the intended recipient by return email
or other written acknowledgment other than an automatic &ldquo;read receipt&rdquo;) if sent during normal business hours of the recipient,
and on the next Business Day if sent after normal business hours of the recipient; or (d) if certified or registered mail is required
by applicable law, the fifth day after the date mailed by certified or registered mail (in each case, return receipt requested, postage
pre-paid).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: right; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are in agreement with the foregoing, please sign and return to us one copy of this Placement Agent Agreement. This Placement Agent
Agreement may be executed in counterparts (including facsimile or .pdf counterparts), each of which shall be deemed an original but all
of which together shall constitute one and the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page of VBIX PIPE Offering Placement Agent Agreement Follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-5_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page of VBIX PIPE Offering Placement Agent Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aegis
    Capital Corp. </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    Eide</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGREED
AND ACCEPTED</B>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing accurately sets forth our understanding and agreement with respect to the matters set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Viewbix
    Inc.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amihay
    Hadad</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex10-5_001.jpg
<TEXT>
begin 644 ex10-5_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !G 2<# 2(  A$! Q$!_\0
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M^J1W R8C\LJCNI_PZUZW'(DL2R1L&1P&5AT(- AU%%% !1110 4444 %%%%
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MX^T6Z,X592H+HKAMI_"IZ!!1110 4444 %%%% !1110 4444 %%%% !1110
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MH PM!GM=/\6W-E:2!K.Z0-%CH& SC^=6_&I(72RJ[B+H$*._M4WB33KVYO\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex10-5_002.jpg
<TEXT>
begin 644 ex10-5_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !' %0# 2(  A$! Q$!_\0
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M-C_X#I_A110 ?V#H_P#T";'_ ,!T_P */[!T?_H$V/\ X#I_A110!H    #
'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>vbix-20250711.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaqGCbP9z5Z8qekhvWBwbYna3yIkRnf1Mynf+MqGITAB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:VBIX="http://view-bix.com/20250711" elementFormDefault="qualified" targetNamespace="http://view-bix.com/20250711">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://view-bix.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="vbix-20250711_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="vbix-20250711_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>vbix-20250711_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>vbix-20250711_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="vbix-20250711.xsd#Cover" roleURI="http://view-bix.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://view-bix.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 11, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 11,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VIEWBIX
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000797542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">68-0080601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3
    Hanehoshet St<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building B, 7th floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6971068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">9-774-1505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>20</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://view-bix.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>vbix-20250711.xsd</File>
    <File>vbix-20250711_lab.xml</File>
    <File>vbix-20250711_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="20">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "VBIX",
   "nsuri": "http://view-bix.com/20250711",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "vbix-20250711.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "vbix-20250711_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vbix-20250711_pre.xml"
     ]
    }
   },
   "keyStandard": 20,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 20
   },
   "report": {
    "R1": {
     "role": "http://view-bix.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-07-11",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-07-11",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://view-bix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001641172-25-019503-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-019503-xbrl.zip
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M4\\.CB:_?BG'Q)>;RCV7G\4BS5(P[CT10IE!/\4FX",+!"F""S$!.SP&FSR
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MVJB ,QH>I(U*:L]6BWG01O=BT!T"=4&QI$<SDO-!DO9BT+96GRHEE<F60KS
M>+(K4<2+4 5_?7[P]Z^#":7P:4X@#&=Q5:92/7F]IMBX9'9,P\ I!A<E.#:3
M>50J/@BEF-0]L52[\>A0HM-)BK$]"LKQ!VZ0FB/]'@.N%TJV(4.+3:$P:1&#
M\BJII5N"^,-FV(=!NYNAZJ1;(_@$2>*:X[-.^4YBRJIS^.EMN@I!_M9H"J6Y
M?H09K=:Y]PE<ZT6<RN^I[E]P!Z-;([<6,0G!,UD:S=.,D$>Q1C7PHV8C\(>6
ME9E"^AA=OP%3C,+NL .QWY4!#A2+J;6X), LZ(/W,,9!XO=AT%;B-<BK-W%D
MAI"4X%B@"<<@PH.([,.@K8B8B_TC":$<C:";&^K^D[BAQB-+#A7LYH9JZR4/
MH(FRV"+U886HK?M;)F(F4%Y"O<#BJ@,3U+![=NV>(E8JZ6:>QYLZEHH4690N
M46%.27D@5!?39A-BT+3B5$[HXQ[4V?E91SOHQHHRISVJV(Q\Y.CGE<PH>'B*
MVT<QN2<68H"]E@CN3\$6R0><T'X,VJGICL0/X]&9P_SP.DHST%@?)Z;Z=/!B
M[<F@'R)3P46T63:I7P?A&H3K(X1+5,CQZ )NO<WC"-+?!RG:AT$;*7*IHL8C
M!J0%.X*4'KU4\R<Z8,GZ6#37S$Q>V+(_7FD-(U#<^FV/V6!Y#*+KB:ZA.>O@
M4N]+.UHJ56L>+H<YK%7_>X?(2YW2.\4EH;DUHJK2Y'[6VF_31.&?/E74(,<[
MD7?/!^3=(R+OG@_(NP%Y]WF/:DVA.*/<URA[M("^&NR>O1BTE:5UIL:CH^?/
MVQ>]8>9T"3]:'*6-'/XF :4M2$[-">6E3HNG,ND@ARM0.%&>B>NRAKY38_#?
M4 K7FG@]4I)PO5I-2.*4!M+T#NU.PFZ@%%OF?42G9L;/5- 5DUR+"@33L8Y'
M;K>'/;$/@V[LB>=/^_8$?#/LB6%/[,.@S9ZX.CW&U*@5F'&/IFP,^;_[,6@K
M1.88[*$?8(L]=*WXP:P?1,<3G8>1W%ENNV<#M]T@:Q\G:W3 ]!Q1/11V0@Z%
MRALR*0F)/$.=M;]R"]T94PBI#X+5&,Z[009!TQJ/KJ+.&ERH<\FS%3X84%T%
M_4P'\]C3PT,4V4MK(5S]="Z%)(B^V.4$G1@Z*R&R&X\2%--$2.J(VRHKXHC<
M_4+4-R_*DNMP=.^0_Q&ZWDMT.Q?E=\$\6ZO'6UAY%4UW!NORI*HW&7R7%&LX
M* 99=YBUX78G:NT.R"A7?/*/5%85HQLX1_'2QE#HVA!PKZ*4&33;940J RMU
M2"W)+%^IF"J78'VPK+AGZ\6\[V]E19LNR-%&%J)(3+F+$(Q/COHV922].(?)
MU.Z 6\5ELF0*.IC%0W/SP [V*[<G&!@I>33PI8=#O8O2C)DPD9?N?\*.&ZZ,
M1]U&1*RXZ<2.;BSSXJ9%CM@1I 6+/Q"#WP*<">=9"K=]C*(&^S*K[+5 E1\I
M2YH=6?QO1(WVO1OQ"*PY227MI)EHQ3B'09KW8=!&FJ64(#+C;[I "%@(LG 9
M-5<ER&"ZBC)3A?#GJ'ROJ-YAL5(Y4VGR5X,L[<.@V[+$$M$A3KDYEFP]N24]
M7+DLTY4O<@T+T- ]E &TK7G&1>3\"I=PQOZV1K!]@3@%^/CM/Z].X>Z'H<0X
M-/HHJI+H-Y-+Q7WWOOHQ*^9;O[E2F&3C/Z"D^";U>CS2FC]_>WY]_)^O0OK/
M_PN#BS1_'YSCWI&M--&1AW4<JZI"(F7A7#>S!XI8 </]'Z'N#UOL,;>8SJ.&
M([N(URTXMG:A^&X/U],;/@0/V<GKPK0ME']%B,:**_Q6IC9US9A&>L[Y)TDN
MI:TDNLNDB.AV*Z%Y84NZR8<^5/5Y+ #:BP& ]H@ M!<# &T H'WVPWZ!N1(]
M6>"F6.!YCOXN/K5U4>!:?QG="(N^5XF!CE8LY,"E#J(D*87._\714[!*@ZLH
M8ZV+JPM>@(6:P6$>CD?GE\&WWSP]>O[DV?/GST-SPAMM9?NKAW-Z'P9MA/@?
MOS2HS,7-N! =%Q7U4%N6<'PF"C$,Y%47+ TS%;;LACB+UI62.AY<!+#ZCLH?
MI1W\,BDI)[G8#N.1-1X*K';AV[*AF!!8&4(J.M\K5)'0:0*W3V1+OG2\RA03
M(J_*1"I+Y J=HS42+<:<,XQ?3Z$G;+ TK.FM!I S$L<*BK!2$3J2>.I>946!
MM6UN@C<'%P?!9$Y>6&^T8/-SW>MOOWMV.!Y%!TMXSE@NQTA"@DBH*5H?S[\[
M?!JL^IZ8<C$DF'DR;;!79-R88MZ=,]PSMU14XS$F%T?;Z$]4>4XUK(_3(R[0
M;4J+Z)CIAKW9? 5ZC!<L()5;T-TVC\1.U+19,)&"+E,0%L9@T(KR)LK3?T4Z
M=5PH9>CHY8%C[ @4ZL4ZMVQ+_!;\ECLUY>E?%L0 B@I1,$\3$>D5TC81]90W
M_[J84U683ILR[%B_!:P"5O%CD#.Q,1916HI]'V 11L4E;$SK_IQ4C;W/]#YJ
MI>B0H@)$44JI@Q79VVPMW!1%@B^"VZPS<<6I581N?&%%[2CC3NOAUJ=BT$)/
MW7(JS^-50UTHB7VH#]#EBD-SO(<-LP6%2BQ$<+@.]V70YCKLX&HQ5^)6LI86
M3DLVC_Y\D*-]&'13CH0EL-,#M!5$0^<8U2NTM0H7GIMH$*A_WZ#] 6L/A3_>
MQQWM]Z]^F%U>GQV_.1V/SLY@K5_]L$=#OWAW>?S3[ K&/GM[$ES-WISNV01H
M8?]C#/K?M,.?'AS! -_](*QE>&8>!.>YQV1V0N:H*>2*^JC$Y2UI*GE9BCR1
MFIDVI(^^Z#0/&[D>\*CVR6A_]G@DO.9HCD'C0K6VZ0"UB+:HJ<[9JQ[ZL )\
MF$)$H!AG%GOKT!+ -VA;9<*BAB89D5:"H@'F!?X>?Z[!.C@!4NS08GY0E\8\
MR _IDF$P?WU^\"* E<BDEFT'_.>EJ8,9!K?%/?8A)(,]U/.HL)!I39^AG6-!
MG,86J(C.C4I:%AE5&HUA"HA5BTU_0C'<I)1EPRDT)AW"#LB;CV!2%S?,HV4B
M#"WL$9P-"ZP#BFB@L!'&8$K2BGC"* T#S(R;LJ!9ZVU8YQ/)/=L&.]GW!1/&
M0_%K8(GDXI_5=9G.66XN6"+DUD<+_+Y89XE4U8Q9]HI[*HBI/L1.K<Y7YHG@
M_%XH4H,WAJW,JZE*Z*PP"(E<+TO5&AN1:<6ARZ+[\"W*M>*8J"-5G=ILBN8U
MMRI-8<E,; UV-!8FK='>K-99+8 9L/X0$V;ETC3/YNM<D9TKAE:C7WXMTH/@
MU <.LYTFFU$_? KR5MQSN>4PN$LC6-H2NJ&=G.$V;!B3-!MY;*]Y!RC-APEU
M@]\DN*;#9N-1:ZRA:RC0,=$:70,VC5L,IGK%)DC7=@X;1KH+M):,H_&(^1[;
MKR?3>.M\P\.\O=):+1M0*8=-4O^ 9MDGHCP(WN')78$<5PL=)A6I1ZZ+W%A0
MG>>W?4]%+\('GQX\"[T;0BKW,E4UOYTK4YC]U:S1+2XKZ F-CB&]>/)7WM'.
M#2_76&\MDU/] $N%ZB3!RE;0L#NX,#O8>!GB*(O7'!U%SXS/RPD6@TSET3/T
MW4B?/63RIR1O8!UBV7Q1_#XO[JD@3=)RRO"A[;I/M(^P5"L0."0_9C=6Q\](
MQ/7PJ-AOQ1'CY0H.SA;UZ.X1.GQ4*5\PV88V 0PTU;7.:?.8&+=PKB2"?H4C
MNS7/M:X%?1"<V=+&(7$Y\N:Q L"X#KX\D.1E75$"J!?CCN8@NW9]G1W87M^/
M&/S.Y27_IPZO=TLB=$!W1R=4V)+JKC>MVQ;%.?&OC1)70 X];HEV\.ZFV/^]
ML)[!R6SJ'D#FR'7=GBM0%8LDC?ENSO&L9N^FK*NYQ6U";TCK0R<*WCJ<5AP&
MDU=3]#46I3)M$Y$>-@NG>NQI<\>V O?DN/F[^S*M02G"/4$76NLG$BYP8X-X
MB-&^X8/,7X:>^7*FE.446H^-LO0QJZB+<ONRV:.8B?:,A0;$B>UZ()SJW,V(
MI:%8;:!9FB<,!7?P,G/T*?BD0W>"6U6V*X<3(M=GBT?-1TW"O1. .0C>%C4*
MC_X1"$V^ =7>'FVXPTL$ZK+5T#Z2MNH(.Q2$JDDS%C8WE%SO%I^/'G=71:8P
MAC^+^%''-$X=;+_)9PF9G=GH:;*7;)R 9Y'ZXDUC4W]578K<1_5.7QP8J0H=
M;=)O<SSZJ$:;W2068%\]^I3#>4J@Q8_2UT.Q3Q^J7S9M+[BWV7*@=;G'C8CO
ME^-_I[7@:K^@@A=6RV:%*704$ZUTP>08$YN\D3F'^[3.Z2EUT(W"40Z=\ [+
M?"%[J"X.@NN65>D*M9F53OW)9SEK3HF?GL43]+#5\5>FDDYT[VJ:J6A=%TB\
M&I-LS?%B2-8Q1WASA9(!QP;)"8&IL#^D 6WT=06J#"B5H$!&*U!!KJ&38C_N
MZ*O/-@ O?G[P[;?_P7!47A(RZL3>MZ;&>/0M/F@$NNOJ:<5 W1/5LZ#ZKPU7
M5!K1NT*,0]^/8Z^,W^4*#XT;PVBONY:=EB<'0<$"(B(N54#3]&^<):$1M_/T
MA9SZ7\#=)ZTG*I:*,-_!<N1]68#;<9-?#[C)1\1-?CW@)O_$N,G/[\1_2D[\
M$W8""<G)ESW7_A!'V)\]/CN)0#<^E\(;;353;OQ^AR?6!T/$H/AMO.HV#;^D
M!S3\;L_F^0L*U]&7$JUTBK:.%W=+UJ!EF;04WPFS7[.SEP*!$A&!0G2#)N(J
MS<7FT4?+,9AKE>)*4Q%SO6^#"K9" FBQ6Y-POR9W/^6)!2HN5B8 G):ENBMB
M+G.65W6YEM"3R(S)[F"1,8^( [3Q-?Q(KK200-XYX5 3HK281U6*P3O0X<$"
M *N5DF,5E7"-*6+C&*/B__B4P"57A;4Q'R6<((TBMJ%0VRLB5Q8>!&;Z6#1>
MMU]BLI<[XPXVAJU7;,$2BTZ\0$?(.7AZ<$1QI-;CCIP%6\7,A2F,1P)^V1U!
M,7N$PK@(L>=;XF-B_289 =OIJ.KX\$W%_G7'B\6 "--)*0[=5_^YYCC$?HG?
M/NZX.[J)?/CX)^V4X.,W"GJ-=*/C4<<6$6;2G;+\_.";YX,D[[LDL]W6P510
MO405>Z]F8S\%0$O ]EI'VXSY+^,ZW$,I:7I+CQY9&.8/\0]N12!N<Q%V8'!\
M9*B?6<I2^:6=B)]WQO?QQ*'SQI.&L(G8;QTV@TF[5T-FYV$G>OPC#,/YAG#F
MEDM#&D1$$4%%-(.JUM?-FT0.!PUH#X8LCL7VB?31&I$OFH-2].<((6.\_)F;
M] 8RHA,?AKCY'L1S>^>"PND(#2SFT)W(<(6X>JZ%]?;0\FFA0G=D(T'2(>JQ
MJ3:<'[)4]7X%U?^( OF%8^VDR*S+*-YH]AC,*BU32L"@'+0*<:=-K++)$=("
M6P;W[,%$$"B*(7H(62^"2TVWB>PO\.C/^A6S!-,/U'AT2LC)4/=!OWJJ4?6N
M\:AW1[,/&,MU.M%,[^1<GH@0X0+UGZSS#/'=G&\0C4>BS,6<AB#^2^P4YR)0
MH@E\NK'(7)Z]6CW>[(U'VZ:O8XJX]X:,:;I?<KR76Y>"V)C!8>^,L)%8Z9"Z
M@G0TW"V-W+F5*H66/JJW^FW<^G=SI?+QR/QT,',> &#^9@ P/R* ^9L!P-RA
M6PV'ZZ-8\K?*LH' %=Q&11!T:&N"/#(QMHA$!HO^3VYD2 3DFC14P^+08=TY
MFNE@X/T)!&ZPY+9:<I2&O(P2KK']N^TZ[1OI,^J('8!I3C^#4?>H-EW71 8]
M\SA8>_NWO3_:VG/WQV.9>O:7^S7]^REQ72JPA[QXD/X;=>B_^S65>RD]=U,A
M+&J=(7G1=]&QJBNW7!/GTZ"'8<ZCP>&T!T,FD#251FBL?D_6J10#$"A&FQN)
M",ZL/%;KBFCM72RBT$MI<%F#M8IJ(G067B3ZEQ"O5139&L:U-3_6]M2A6KI1
MN68'W5I$0GB>^@8#+\V0 4-* R GV'*]U)40NB9"59@FEU:W7 +!Z=+];5$1
M^B41<\#M%L/'P82]H\P'>%?!_%7-J<D+C?&+@GF4OR?K%(-P19E"SVQ'$A5G
M$:HK*B66&5D7OR8P-&9J7]!'2-5R6W"/<5KTR_@4HM:)*)"JK>96^49:#_(
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MA3R(1 &._:">(C4]NGM6%/JBTTGJII6,?R8Z \+:SYG:F2F-6=VTQL=!<-8
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MZ\T*%GI:T%G*T7$JS^2Y=G5(BPH^8U0 EPIYP&B/NK P/N(:\VLT4J3:IP6
MU92IUAU'TB5;D5('V,8C/\+FE*:<]M8#ZV@GZ&W&B20PP;>BWA/5=J@=[J"O
MP"&/18!"9Q'Y&,EOU!;+"78N%79>TU%'W.?,_R\.:A9L CXYI3U ;JA0<;QA
ML5FN,B77 X>T:SNYC?(N$FOHM >TF$QIB/*MP5;@68'5!NI=S=#!ZK3 THC$
M[H7\F@\(^GQJ+RM=BP3Z6XF7QI+!ZR^Q.U)3V3A(IF 1<W4;6"EG9WBW#%V
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M)PT3-!50%N4U)@FE5,SX'F@R=EU%U3B?$"88"_" (:$XA8T60Z]SE; #224
MTG+N<4'LK^*"LR!KMB&I$2*.]YK!%0UY,H1LSH&'"G(ISXMU;C48)^'),C-V
M$PNBXMQ,)S.T36Z!6%26F?]Q519<?'XX)O=@T),\YV/RG#*U" 4J0-H94V,<
ML[-K=SJ"@W7-T;+I4=J-*4BFB]AX!?H9)5DLU(4>-<J7':>VTM0.H*U7Q\ I
MVX2/O3NX.@![+1?G9)0LTUSC!+6#?M=,Z!Y06]>(C5K#6T\4>OIHBTYL?OSY
MZ]FQ5^9ZS\3K$Z*[3P^'Z.XC1G>?'@[1W?V([GZ^.Z(H^(Z@$^]2@<)P418K
MA8&-GXJ,E(YCRT7?5YW0Z%^YPK@)AS;Y%"T5LQ1RF[?2ILMOSPE>[&]S,KPT
MN^7?O_W&UA&4\O&7\)I\C;U(%!?A^_O7;A$^FZ7L5Q*L"B'M!]5_A39#,_C,
MM8!4]0=('QN4H4<5]-6*!?T5EI.VHFUJ.>Y6@@3_VU2X+:>J0X6@-:2NMXU'
MIG3D"T]J@PG^Q&H8KWXZGKD:AO:ZVQJRVIXU%3I^I*RJPF;EOV;*B$"<),'5
M!E2B);UI/+*O:CSFZ36_<U**^UQJ5Y"*U<\C.QXM$/D(!T5,JM:+_YB:2*>,
MQ@E$,AVJP;C'6<0D,G<%!_ <A$.)U-UYO7GBM=]HNBX0[\@Q/G)U1Z;R.+:/
ML;::D1U=RPPKU;\ZC<G]Z FEP+0SH]I#@"%VF=6,T3&+C#4 BEXS:B"'"UAG
M_9$Q+*"/3QF>%''9-;X].UKV\SS][3<^3W\FGJ\W$7E^#.LUJ@AXY4=>^8RM
M5#A4^H?4B#O%&H3#M<B<?@Q<:-?'&X\<_Y3K^D#WW)/W2JTT^1V3J7 9";_F
M'_6/;,N8.Z@MQ&L7\G)I?F_.\&^\\K^AUQ<F0<O,Y%#>&!74:#C5N@N$U[:R
M^$0S="$NB(F%[.G=7 -,$'(YVZ:"],D+ M5QF/2"N1CQ<2YU(5 FCA>N2SHQ
M?+J>&YR<T"6(0<*WQ%CJ43E/D?::SO6[(KMK^*SH(&N8]%WP^\[QX+F$&&TN
MX&A\$!^3IUW?@C9:JWR@L]Z+04_*TLVJ0_^YK9AZ>F<+S_[2(8,.3)$S/#7I
M!6XD(MJPFY.X N4\PM+-S$WQM>L-;W*\N\!0$U!W[O\5O(HJ=A1E%7IP-<PQ
M1:!EV7"RH5H0KREYQ'C;V-<L?S9+; G;+&;\&6RMLESZ#K$P/CR';<-I^EQ=
M"SOZ]/ _FFI4TR7H:FRBFFD=RT4GQE&&M+>UI6!FEBBKT*V*>^R*5I/ HEP6
MB+.:1!I@IC@/.8%NYIR(2POQ_/!%+TG(E @3<B9F-!$<8]L*>$(G3$6&2Y6&
M2XB0"2*J<(9<YDQ:'FCFC@2&<1@NA2;,AV7'#5N_Q-B)^U/O*&^H9PX<19IY
M%24XM*+4;TL:HH]35,68WV\G":1UDDPG1U."Z!3!Y(Z)?GNK?D\BI]O=F\N[
M@ ('<AWU[$:X=NZTN];MU5,NUX?_?-;!0:O5X<0FLR(0I50,D!:0H*'JQ)]U
MKE!S9EN]'(^HF^T>L#HBD&S&$=8$73$7/&,EF4G75FEJIY*:8:NIK3!L:U)Q
M\^.12ZH#;U\9JC;;N%,@S*H1P[6W!X.>5)7$?4C>.\Z2@^#<0+<X-<&@J&8<
MG_&.07'QW4>E0< )PXE+W-N[KX@O',Y.$Y]% F/AE2<(V*3;(3"%_;Q<YV)$
MN+ U ^U;V7W0DQ;IP/;<2WC8"'LPZ$E=:_VOEK#?5C70/=9UX79T%3>2=TS9
M47_3H 3>EP+C%  ![R-.!QF/3B3&.9%$C)Y;D#B8R'(JMEQ6!C="[AOZH2V.
M%#J4^U%516(=P72%Z.$VE ]S1=1/<:WI0)DO]G?UC+"@A#/78%"7*I9.D6'W
M[0Z5'@VATL<,E1X-H=(_<:CTB^SJ9P=/!7_:+MGWBRW9U\K^=#"*3J[B@O%<
M*EM0 PNJ**!+ =O'A'# H5,@O[R4"*SZBE%PK9J.&D4-* \^M8!=7MQ7P62=
M9U+YAN(%.IN26ZZ=*J%"K ,]) >#CK;.=<%#3#ZB1KAT"?P]_6YO!$5:MZG1
MWY'S9U]U,BF9>>Y4:7D9S+1'F??&52N75 )F44[V 9BUB(4E5Y .725K9B[1
ME(^)U$I9HEE^!X-,'.HKWC0@N3>8SVT<5-;;H<O&X+^]LC'BGK,O$F^Z16N2
MYH5TDD&)A7-#RT(9DL=-*M.'G#6)V7NZA@KGZ8CO6I?@(+\7;V#C=O?)4"3N
MB"#>]7*I,:F?5JJ<XP06\FKK8:WK%ON5=8 :."Y[&4B3%G>DJ*J2WKD]ZY">
M%,XM1E7/6XG%.ES[2<-S@DLD+S*E_Y(Z!ZCRFS+)=MF0R[2];L'698LT6W[E
M>8'$N8GMF?/0C$TNA:Z>4RT23X_FY&IK5--X>,YY-'[;[$VB>LRR%%U/=553
ML9AV*02&6/<L<S-+)8\V9>=XIFZH1O(\E6"-$9GVD)&:%E8[YE)UT4V$-6IH
MB.V.H/A11[0S<3PB2ZHR*P+CT?S5Y&2F1L$6R^-TE;6#;K9R%-YBE90##!LU
MI$+T;V-,*UTO Z=XG9P0\D(3]F.)-Q7I97@:W\TTUX53[Q?/B$JWDFD^77]0
M]"[7^,()]XJTX<3*]0S2:G<0#NS7=:XYI9AN4V/0[1QA'#1)E5L3 R=D@8)<
M$3O2,K?&(),&."RY3A%:S$.?*WNVS3?-W($]N_#V\Y:7$IOG][DFK^R\V1W.
M@R[V <($2)@!4^[+E#P5-G#D!%3X:&>V!Y4[)+%;@A@M/F0IK.. AY!UF> *
M2$"'B $=TG9[6>E#)LJT'H]!,EN/$+4-[!KG^ 1W*<PD;&.IYI9@L6C:2Q3:
MQD@D<[?P87GE09ETX([O6RI-YO-$/V2<XU'70$-=TD]7[J+*A+I=KY<2=FKV
M[_'Z8A&EA80X7>=P0.:.!399.:)JWI)*M?&HV"OA^^9!2%:WDU@S'MD1.E?5
M[QQ=MT1-B!?&K_4>.*7>-RPN=(H:.6@S)='E@<-">6EV9[4NJW5DRPQ=ND7)
MKS1_L9_AM M:(T O"H%WC*N:=NGNO?O&"Z!3[+E=6HXH!*2\W'!U[,&@)U)Z
MS8J06X!MYH3@&ZKK?6]A$J+PNH^JL.$'<3TDI%7S P6[K^$\(']];OW7#O 2
M-KGX>*1Y"6BQH?J=^/BWU#<Q5U<;L?#B\ C,Y,D1%K*,,/P-*C?^XYE\\ WA
M8O%??Y_V0AN$)&)J&97$HT\O8LT=3@+8S?/U1FWKSM'SYS-X&;^)$22-4BO-
M3=]V4C&CJUCQC85K(%^=R#^<66S370@UU<1V#U1+E17WP@DO0YQ'2)ODS.[6
MXC'T"@22K+.;R,M>;0WP-:)G^\NF&BAU7^<WAD*-/&/8%S3A.)2#52_8B>$
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M$84+(@V 2Z0B<-!< ]Q:&M@C)8 ]4NF>4F7S:ZH ^54?1!MU9;8S#7+J+1R
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MT5G1MK!+FMC5"CTCDL-;U:8:HG>,N@-1<D-R7]B="AMHQH&2C4']<=OS16T
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MIW )7?+GV=)N-%QRU2\Z\&;=8PLH89@_#6M68'O[T_CX=&]W?[*Y\?>=^\)
M\B<]^2][)Q"#CP\FAQ]/'MFS/TK*F5<[!"H[9549=;A[26P^7*WX#.;7/"N-
MO7@=$E>;4M3'I^.,H^1A89L^B9^![?FEL>=UF2)\C,VWNLAUI-'=4IX9K72-
M,M4CGZ%.Q"1S..G-#8G=H%>$.DJYWW2U6,0,&S;'F=*2FV=S4-YX]=>3CT<_
M->=__1;^NVW1L>_,!,[+/"\O)6VM^E-^C,P2"(4FS/\(?G%>7L+#X\_,?U[P
M_#9NN:B"%,L1F/H-B*3.@LM"O<**ZH-74,NX;)5V+@9=B[OE2Y\-^=)UYDN?
M#?G2(5^Z[C./L(;OA5MCPC0)'I\\:AX*),#5OK*B/_3J @S0SBXU)4I,F43A
M]3#!B^)H0)+VY"(3^(EP4<PP%+/,VMQ18+Y8-71F,2DU<5^Y/^-UI?G=<@,L
MF1%@AG5@B]@5+#)31E-=$W^PN*"1<(O346ONC]@/&^%[Y;9 _A:>'OY[*OT<
M8R RH\EP$'5SV(6"9HS1X9,V]TPRP(OT21)?$55L+7*N5/0'2#.M49XV4(UV
M0HX!,+;7 DE> B20U3=4/7E[!$G9Q3)JXC]2O2SNYV1%B(+T(J.*=D"PT4TH
M#UJE2#J)Y>%$?HS&BO"PDZ(!I63[>KD47$\6J"G/6!_3P?M(PI4*!@+'HKH,
MZ+DR=HH^2[?S,(M(/:0[*D)E(LDJ&2\97CBF]F#'W/Z[7@'E7YI0LQRQNB@R
M#OB(3_\U0FW/R)&_L)'0MQ<V_ :M)V4']7!58H^20NC4+]**8"!RA<3-87C&
MAM?P,;Z&+UF(!DF]F6M #@Z"\"';MW2R^!J7-:MT@JG/]!$&\9:5%Z0.52NE
MX,)D145CMCW1:JFRGQ-Y.C,W(&BFD_#EV#F-*VCYA<B0V-0MJHW8SXN:]0Y&
M5CY4)!%;#Q-EM3X7+[(X O6('(B/C+]#H#?F(J/?)PDBO>):.5(\K-JL8MR@
MS&*,>$N\!C\]I*8;P@)F5(U]]>;%TVBYL]B)MLSB;6[\5E:_1[NH$V(>9=OO
MD34Q-S&=PXT*LS^\:+R%[;O#+#AW8G/C\\X"/E82"VR4*2:]QP$6*B F8WI[
M?Z*BT#Q1TY^:J=FVH/Y*P!0^QU1&D=PRE6$F$)Z3<'AS %42U=?'G9.=B'(5
M","NS.7/"N2, ZA6@>D*X'O*8*>GU07/-C#$$S/EK(&.1Y'\$=R89#8NS\N%
MMU)*/A1+)>;UP/>"CDM9AKGTY\J;2T0!WDOKJ/4^?<U:BBE*P&ZMDBG1IPFF
M."%=3ZIF;<(I6NSU.MT4%*^RPBF/YB 9#E1WH!)F:0Q=P^AN_1C]BKW"KH>Y
MU1T<2DAC>W$RXN9B^)=Q+9?$,\C\;POJF!5I;+"DD@JF")'@M/ ZP_?;$.*"
MKF"5$-M1HU831I=3D*D)F'^ -C?1JZ<[S_X"5X;^W8H1-ZK82S2\9>%#P.&=
MG%49(9+&S##MG((M0"#9@U$#CMX9DS#J#-1O*=Y&(<X.7IK:M8US[5E9*<NB
MJ65A3RWS@9: ED(M&O(, W]L6X$J8]I:-Z]^;WC%PP"UKMI\E3'$U!R-#E<"
M^P1^RLSS <V%1GI#$ILZD[W6^&W!,_O:VX%;T$53M;:;&WT7%<(8Z#_'%@8Z
M>'#_2N\[/6Z2SF. .X0UX7G21@Z>0+5VO!S/=:>AI>W^T6$7"[T(-G?1&'BA
MYRL\L%#8S!\=P"8PN=K8@08^Q521MQFNH/V@88[G"">!402EG!+M0H7-P#A0
M@MOSF3"P%@6, Q8JJZ1WS7)7V2V)7R<_'=<87TK9=6Z?T:[L;@2G8]C9=U1O
MX08PT7N%')"J4'4X((G:^R)U><(%)-D $=A_B5 ]RP(=<;KI105#0,%!2&&^
M/7*]N3F0L?-BF5@#73,>VZ>QX8IT.J..#'#9-C=:U <B,D$[24-)??JUP1.X
M4\WI^5!S6F?-Z?E0<QIJ3NMV=PE<^R'%&%I!\L_Y-\P[3.V"%."9F#4C&'<!
MAU%28MBO! -B/#9[NK4].FSK(&QN8$T%#W?"#*@H4,D(T?$]V./'N%4)_GNR
MFD%!K61BZG$-$5(=1 <%G0#B+"J0YI#\G6E:I//,!C\V+T\^0(;Y&'5+XV?:
MU&A,=_>+BA #8B(,_]A^!SC!P9Y56?5 D#3=?)!>'LL>+7]FBVM]D&DSD1+6
M$*KMMFP$C(_')AF7W(I3\+B"Q/D=;BT(O#HBRCPGV*?"!=6Z54-L1UX$'N(/
MIZGT 3FQ!@XAIB;83$9A9B?Y.N1^]9TD8FQ)D?76RC$=)CR;\#GN@U'U3FZ%
M>30OWV"$G!%ZS?46L#55\H3X\]^B!9E1GM*=H4?&=Z4WAP %UAYA=A^^S_'E
MU'Z_3VN!T(A*R&CN4_"KYOL7.\]L_'+C5=H]8MYUGG<L:H#K#01Y@O93*B76
MC"HY*]^B1AV#*L1R8$:%4\[=AJ)W-&,Z2;&YP:7<:2K9((!'C!2<D$S72+)N
M<>WXW7PPC5:.H"?P LS7@P?R&%]^(GO_F>I#YE3:CR^YY&K>:^Q9%.:-&7]"
M4GN"^!E%%V;0">J^Z8PE.24F4#3OJ\\VW:--9FW)&8Y&D,^)IDQ$;B1^#X))
MDY3N";TXNJWSI.'"F93H7+L056T<G6(%>*TET^Z*(A'^8"XHV KF/9*DK6.M
M@4?(S15S$0''B*,U??ZTU)UY@Z+O7*2EFD]E0?&D*'O$ZB[/";+2$3#C1R)+
MAWPZZ$(Y.Q<KV;Y;")8ZG5(KH>ED,Q&+ @-2]*=,ET5UA'Q5FWOF5XXG!=<1
M'E%DXU#RL8YJ8VR9.Q,/$>99DN7VUHM)1S+C6%V4,^2,KE?31>9PA?;6YD6L
MLCK)F"!%-PG?812CZ&U)M,KFE[_$Q3E4,@M[',0):M?9=P73N%F]7#%\G9'\
M*#>I(6[P-]S^9>7D^32#E+=C^.D!)I'5LU5=6R4>35X;0ASY]0BM\!C>9JRU
M&IANS 9S0S6_/4R+ ]0EE>5,'5O1'_<VC;S6-J!(RVRAGN1-,8M<^[J]>AV]
MS#6NW$@Y[:%[HI>P@*0U,>P"NPV2<$GJP(S"_(.1_Q0]V"_?M/=H,NS8765^
M+E!+:P4%^RJ_GZ8H%TL"&S1G'+P$GP("J)@IR#VJ (26&$,(A&0,EH%>3BST
MX5<PJK,8 @NE1)U>KPE>_K2-@ "%@F6$AH "+/L6SI@@ Z _LPE':FUZ,!95
MHZFR6B*2KSDKRX0LJ5(#Z9E8:5,1RWY0MAG.^/4(%($HQ:,8?ETM!1X?Y4SX
M7OC6.L-,E17E)YK% 5TID9K46&:QB;#I@@L+U1QZ.7W_,109;FYH[.)YBLSL
MGNY6NP&HQ4A%R]-1O3;GV05O+L$]7_-",:<1%O*RQ10TR"Q4&.$5[:O-[5%T
M"TE? 8:UA84=1%NY"TKQ; 3GO\5C1RPD42NRQMXG&MSG.Q547@P%E7465%X,
M!96AH++VQM6GG*8VQZ>)]5PVZ(9<3,\!6N-U4@]((]D=W:31>#P6@WU]E%N/
ME3BD+^JZEFGF=D9'N+DL20FC2H5= ]P("#FH,$ (,E0S!:ZKPG5QJ$B4M"\0
M,):2SB]&?R",$0<J@%.S8HM4 <+Q\OKVJAN"4'!6@8*=9&AFLGAO$;90?<.D
M!45N/_=M@*=K>6 D4UD8IX2X1ZA>8^4\[%B,H\EP]8O4JNY"4&3!MAIVC>-\
M@I& O*(8#<=22]A9)G/ATR)$+&"58\2O,D6RNS)[M2"C :55S!_ALTM52U&V
MJ!3LE?3'F4\ 2@P5R<H:\[7(!=ZZ35;;/;'M'#Z<"/&5!;Z/DE=\@< 3^0CD
MZ!(4KD'<V7CZH#IO8X='\VX.-DK9*&IR/4'B<Y+:(C/%D1Q0"(Q\X"$3O2*0
MCYB8P]C;#&H..7=$8J:"DI*+98I:V5Y6 _)UV+F"[Y.)ZG),1(ZBBS+#D'Y5
M<) (T=.(JRG 5,YH,<PT @VY&JU'SD[T0'; &JJO3WA@*X++@B&>K\R;WGW;
MK,W,@"9"M'$$,3>*"&](F0A^H-B*# 9*,G2Q%;'49M1  C!%2 7!<&S,J-01
MYUG!&65,2"( .<?<,1KO16I"9DQ)S<ZSE/T5-!Z8XK'<5_F5^POS;,6<H]!Y
M-P3Z6DJ)V^P'LX%X!Q!'<I,M5Y3"HV,"1)0L%%72RD7;:&:*)NPJNBQ7(,Z.
MQY ]+]U&P%S")^T R:+[LE<2*#/!,"XN/ 9U LG0(2-RJ[TZV-5':5>M/LV,
M$<Q(U68V7%+%E^;4/88\F_0P],@4M(@"/-F":$L1XE J3S:P:,R[MP#<G6T-
MX;JFOC)"SP_Y='Q<LF"G 4:/6<(1B0YRQ_\B)EVWDCH1*-$6AY-W;4!OE)22
M1<](19$X SAI1H9#9_7@N;E.04HEW*!L?B=0%LH/M@4NS/N,LI>SC$9[R2N"
M>42X6UWF*187C&E&CE<@^<?6/Z;!)=12F":('X>R_,!8?P&6D3ZCYTCF#=.J
MQ@W,4SHK"*@GBVKB4ZRII)1:K@67K^5M"!]T,S,06K- )T=E-RBYQ(4/D1=R
M03IP%3=M4)>!NU51#=N,E.46PN+5+5Y! N+3NJ3(=^$Q+/1H\_)M.GQ2LLWC
MLS.HD#8*^+^LL*LNSI+6HKGJ1VVY%0G4 6>&R&_VL^';Q'D\([R]OI9N<NOY
MOM X*H8+RU#(X4J5+BV$A5,54NJ8X4-2+0-3U#R?9N I[Y*!JNEQGD0O^21R
M>\=KKO#<?;V;T"))YYO>6RT"$N/E+4Q<FY./FY=U Z0GQJ85U,YN+E%>F3_Y
M""GVH)'0%"IV,?J_Z [B+_&,2_\P+TEQEC(;Q)0J9!E1;Q/_ QCC&;PC.3&+
MVZK@5LO6\1C-1[9'A THS+&9KB)+-J$NCQ=!\NXX*LQD]\[+*)JN&B*H8ZYL
M:C\&,*A4%I6\<VT&4,_C&0H!BYB+[;5EVV*FD*I;\\;.X(J]ZE-GA@LJ/]XP
M0#Z(J5R<5>;\!3\#ZI6N)6US8RG5/Q=L("#N":4NJ!BE*NPSLWO-_D..='.L
M%29LW(;R=SDCF5)7H5+<OFR3W#X<$J2/W#2]8M.T2!-GB?QZ+J4+(31L<DXK
MVM8_:&XC?+3'AH&T_59AETK3BFP9J04D3Y_$"VC+'W$O6A>!V?94D4=QFGHC
M J )O'P>U=4-[,_T*EMP.V1-&!%B?*2T@5>+QV8![)!D2(R3!>\XIE&*.E;&
M\ H-AT?D1:^S0$:8T-'\I%UI+ZCH+[=K- R/EEM7!8?0BX!!QRHT11K*HHFN
ML99"&#*:$G!]S!Y!( 8 V3 3H.=CL!]W*F"_' K8ZRQ@OQP*V$,!>^V')+4$
M'L57[#,UT1A*>UQ-U.PQKI3F>I]0=A(H%:7;B?]9V_8A&S3?AF$&/6=-H\"9
M3L3#N@R1:EUJ+/J3-6@(5M<=#P-)EX1*<L)S'G+3W81&PF SZ_7'5:I("H"E
M02?@6WGG>16O@*N-!V(\_A0R#$B3 ]6!&.9Y)/X"*TRB5/U969$X'8VB\K,?
MF R9PS,G\&U,-FCM>A>8=_)&D7';ZR:ENZ9$JE!U.B8DNU:@;W,[4LQI7/Q>
MK9;-C/TAP@&;BPL,&'\[HQP-7!7FVCQ3@]$ Q6<PP3,*H2B[UGC;3YWGF&2S
M61,?E!<Q?;1=-"E%XG)Q.PM-(\5+ .14::8+9!!A6"DP6)#O$JS6&-_!%4=E
MUYW'B:/K1@E!2?VT]IK9!.5\;C]?SLBU&KR-1VF(J>%US]QAF>)MC = 1"F:
MZT7PG(?*QX;]B E_U8W6 JFV6D?="QZVPFCG2*W:^M^H5:V4JKLD(RV&D!%_
M-9S-K9> (8&77T&$!>ZOW'@T@0A[;1/]WF8,-SSI-8CFTA*],-],Z/OV$?GW
MA)=IJQ*XHT^8]"HR3D!X&D!.*[!V.URL(5J1QI'S;#G"TBQG1L@8\T(!=$5H
M=NR\_(YUB3F%EU?$X290$\"KK5AZSI[T^MZ57BHSCIGT<U +#S4[@SM %$5!
M9E1OQ:K;-/#T!KC0.1!4<-:Q<^9>IQS!WXW4V 44KGR)&P23,%G/%#E51B3/
MJR E$IS&J^96U3!L!6M\G@0G$3CW3V>G(XS'%RPT=E'B)DA$:0GR;0PRQVWH
MD.6V!F$V)! 1M27J46D"CRT+7Z1E0*VHR\()#5,?%Y.#2W$+SDYC\?"5<#S>
MMC6H9QW?8VD?,@GT$B>+K,CJIB*H09>!(L#JT^K#DF%A*7\&,"A"@#AB19\K
MD,2DSZG]"'[G/YU08/O]O61F_4]*?J?5"6S+CW96O0:A5CH(L[WVDW7_O67D
ML&A8\DM]Q4NSH30OG ?R0B0#X?;";7!BB;WY;TF]%^+GD/L&0O*Q3RO+VHXT
ML,38@-(*?K2??6=S@S =CO!>H?ALBPL#^@@8:%G>6EFF3G<,)/L=7##(;9E9
M-1<_;8YWUH<:E'#SJY%Z_'X-&#7_D'B@_9E?=;Z+-S&>\5E[4AZ-"S2X@LH5
M)-J!_<R\2!A:1N\H5]N1/ PJ&X$-D&YY2 !#\.4N)6E?RQ$=,ZDC,>D&\\HZ
M48OJ]8K;KXM'U2^!.]>L:I.Y10-,Q !**S!XO6:4KF.)A\D +3RD\,M%"]X"
M(X 2F/-A5+4*@RZL"EUY^0B"/-N6O%M.&?G)R8HB0C/GI*N+C^Q&2>7#(:Q[
MI.\RL0B<0"B7Q%?P6?.*X3\^0$(;_Y4V,Q2ZA3HY^A_ UPJNWW()OCQN01<<
MF2!#"8S$MN&.4B7+S&%)7,>EXZ)6M2NO]41*0-';E7%MH0$4^;@=RHEO)")L
M&.F(/TDW<<T&F$)+A*0:6<^1!(3<4+F#,2OQP+;X*%^+Y]0WM:O(,MSAUBU;
M1JI\N@!K^RWM=Y]GQO/[*1CA3!ZDV* I80G,JJLB(Y97^ AD>GN#$_CNR*(U
M&!=>0!(BCZI5GC(-AE/XD82ETH(EDN%I=K9BLM$JM4E<XTIBKI$8)F@@217/
M&]?;Z[V<3 ]A:ZF?P"$B>0#+L&HU5[R:.(57%!BD6,7FM#7!!!%O1B"W6L[W
M$/PNL\S^74?;QND:HY? SL,_SS%L0*)8&H;YQ26PD-0$[%OF&<3-]%.2(0HF
ML;\P(=Z4-0FU\R"852_7X-P5-W!<,DS$.FF&S0V1%FB)2SV:-W:P7,IR0=O=
MVY^,\?IUO/?WR7%T^#[ZCX_'OT6GQWOC?3)BD,<]B,8'OT7CW=.]PP-SO8][
MIZ/H\#@Z.C[<G4R@;!WQ1\R7]T[>[>$'H[?'AQ]__G :O?T-_W8T/CXU__IY
MO'=P<HJ_.3S]8.Z)OQ]M;I@?\-][DY-H,M[]$/WMX/!7<^U]^/H[<X?3R0%<
M=[R__YMYML,(OO#S\61\.C'7F_P#_AP=38Y_V3L]G;S#NQX=[>_M8HE]?_RK
M<5(FQQ/X]=N3P_V/IQ.XS,>#W<.#=WOVNB9P/SZ>_/T0OD7WG?SCZ'AR<F)^
MPCDZB=X?F@^8<>,<P6U@QLP\F=EZ5%JWO2_2==*_-Z L7@THBW6B+%X-*(M_
M[EUQ#W _Q[>^PV#O8'/CU[W3 V/JHE_!4!Z^'X4Z\"@/#3E21RTH\&;)]?G$
MJU .6N57K@^-2B&^NQNOFO.R @TC$@Z)FQ)UO6+KVJ#?,L^J&C!S2)\%WN:T
MO/A2B+;/#]9Q=DO;J;8=^^1G]<Q8K[G[!M]69=1N?X. ^?M&WGUC\G8/X7D.
M_OV;YW<8?!Y?E:OFR5F5)4\696(&G&=XZ*SW5"-.7A,=O8E6RV5: 30>3S8(
MQ*;9'U!?V_'.-V-/[2/:]=2_O'_/^@UX?F-BZJ)A0L!"BGQOR)]Q#X>'Q5>U
M)4*+\)E71EW]L\[7F@9L;<&KOZQS5[V]>A-\+5HN5H_#1A=<RV.]7.]SM:QT
MZ-'XQL__$MY^:U^XEZ_7^H03H/YX\Z>]]O?0(J(/?>T2WZ?1CA?9>7P5?8B3
M./FZ3Z+NN_78=MXI 'V^GJVW>YZE\X@9FXP'?TC,P,,N_!*[\$_S:AZ:(W6O
M8Y%O?OH5:9Z9P[<$/N^,.N6YCJ+0E=3]OQTV(,,+^-4< [=P,K^2X0Z;[JNT
M.>_BBRR)/JRF:84?G]3_NQ/]7*5I87YS!G70596=C:*CG?'.L.X/9]T/BS0:
M_U^5I7D6[6()8EC=A[.ZQR! %IV6EP#[??'4N!7SO"R')7Y 2_SLQ?/HE[2(
M9X K>IN>945T/&0%'M "GZ9Y-+[(+J+OOG_Z[-G39]%>7<5I_G"7F$O3#ZBD
M]R4JR(0G6.>S_>?QY)?QWL&[R?'FQN'[Z&C\\\3'YT3[D_>GT=O]\<'?'N8,
MG.S]?# ^_7@\V=S IW\/<*B/Q[L?QB>38_/3_O[AKR?_]3"?_2[T*=\-P)YU
M GN^&X ]M][X]P##\QDLL#4VFQO6%J$A/@%HI'>C:P -?W^[]P]^D:.3R>['
MXSV$7\K%H_'/QY/)+\:N?R%3]C /Y"\-Z:)>5!*F^.QXKDC!N9!BY+[BN;[(
M&MV[3;GN6CIVS-LFX#?1?]_Q?P]TBA[T^O]U[Z<3453!?3!V5N&$K<*51PGS
MUV_W?KK-'GF@$_:@=X.U!J%=<#?#\$!GZD%O X2YK'D?#!OA*WPXQ!IN;C#^
M.%K3AGB@D_4E=\): 8N"-G=(<X@IG(/X]3_B@URJ=TJP4T6(>NFBK6Q.6H0H
MG%A;#7"G_+T]+.^]>8Z3U;2>5=F2.''&R +S)OK7>V)0AQ4+K!CR$[S9W!C6
MZ-X^QU&5/GF_(F$FEBFJ0RY,]#8MTGD&RH71X2438$9O\W+VN[&D__8O/WS_
M\N6/4?1RYX<?_@)T%_*;'^ 77_\T/93E)KZ-=2SUL-+W^SDFD$T_6"VFX23F
M?0@[_J1*[P-YMO]LE?!/HEUSZ;V#CY.A;&_+]M__&!VBAV@LVSX0N0VU^W^Z
M=O_]76OW@SC)\!Q_ZG-\^_;PW6^ OOOVP^DO^S_]/U!+ P04    "  <@>Y:
M3,$MJ<1#  #^OP$ "@   &5X,3 M,BYH=&WM??EOVUB6[N\"]#_PU9MN6 ^R
M$V>I[BP=P(O2<4]B>VRG4HU&8T")E,T*16I(RH[GKW]GNRM)64[D-2J@.XDM
MD7<Y]]RS?.<[;S^<?/KXKMMY^V&PM0M_!OC?VY.]DX^#=V^?\)_PVR?RZ[?;
M![O_#(Y/_OEQ\+=?QGE6O0XVGTZKX"29Q&6P'U\$1_DDS/K\@WYP'!?)^!?X
M(GSU\+K?>Q-,PN(TR=:K?/HZ@(_K'PSSJLHG\K,J_E:MAVERFKT.1G%6Q<4O
M[]Z^/]@_L=^W/@XG27KY^JHWTF?+Y']C'N O[_Z<#<OIF[=/\(&P(H>W-Y<B
M.3VKECF5M]OO!M_.DF%2=3N;3S>>O7VR_>XN)O8 -XGV8L'I_3$KJV1\N<SY
M[0_V3CX,CKJ=DP][Q\'Q8.?ST=[)/X/]@Z, ?JY^L#<X#M[#C[Y\V-OY$+@?
MA;\/?A\<[>P=;VU_' 0?MGX;!-N#P7YP-/C[WO')X&BP&WR!E_C/V]K?A2_N
M?-C:__L@V#GX]&GO^'CO8+_;J;_:_#8X> ]?1#VQ=3((]O E'_>V]G<&P>=#
M^.W6/H[ET^$)?O3]T<$G&<31%OWD\_[NH/;PK9T3?.KFJ^?/^\$6_/O3 #ZV
MV^VLX0?_G$;_,\O?N)__<T$_[/5Q$O!_.SL'1[M[^W__^,]^\&D+5^\$E@">
M^IYF#Q,Z/OA(LQT<G@2'GX^./V_!_IT<T(#A4SLG>[!JSEAIAC"4DVZG?=A'
M_L.V?MO:^TC[X*Y#'S\+R[45P//WC^'+^!L<Y_'G[7_ ^^'[?7J%,XBCP7]]
MWCNB81S#QKQO&@3N(SZ9%H&V@G9[Z_#PX]X.#84WR_K:QZTOQQN>&.%CO*?#
MEG^F!]#>BI -9!SV=W'-8;T//PYV_SZ@T>P<[.\/>)(\FF#[8'\K>+^W.X!/
M'_U=!OQYGQ;Q (] \/$ %I">"<_8!AG[#+)NAK/Q$RFT89Y&"TVH/M:%)KG,
M"1T>#=;??^8CBXJ"SL[!SG_BT0#M<@SRN'4$0G_RB.:\W$V\!U+YV][@R_;>
M[]W.WO[.50?MFO.B\9O_W<WY.B$]MC/X^/'X<&L'KHJ__?+T%_KWX=;NKOKW
MM?7)11)59_C1IW]Z ^M21'&Q/LK3-)R6,"#UMU_(^GY[<G3]%YS'196,PE2M
M%\C(+V++OSW9_5X%Z&[)\Y<;KUZBB/DOFR11E,:-)I">^LN7?UKF[GT)BR+,
M*I[A\5E8Q.7KX%]__K^O?OW+JS?_UKMZLOLCBR!#?_'R3^[<TGB\5"VQ5Y:S
MF,>Y&U;PXW_,TLM@\T4_>/;TV4M[,O!_1_='2&YR3;SC^6,;>;L#76W2O1OH
M7I9429CRZ ;?XF*4E/'BA^T)70OO'K<M>>/.<9)%,;THR6[<74:_H]LQ)F<P
MU^(,UJJS6+F0;S^KV^7MD\_OE L)NP+G<IS **JSL.K#*XO@/$QG<5#$HS@Y
MCZ.^N8 "^&52E4%8EC##$GQ4]P4?P#2*"^?Y21G ZB15B@^:3?,LP*^ ($S@
M,5D4E+/A'_&H GU OTB325*%59)G90"?C95,XT?Q]Z,\BQ+^]5E<Q$D6CN%9
MW4X95SCTZJP?A!5\^C*H8"7Q$3!D^@Q]/8*C$>C/RB/\99)3Y1XH9U(XFAG,
M*H6'P@3UK8V3E2]% 3QX/$M3_^DG,'48-LZA_N#AK JRO,*Q%C$-NX\K XM4
MCHID&-/VX-NGLV)T%L+8QD4^"7Y+XHMA\BW8RT8;_6XG#';C-+P ZP'6JYCF
M!;_-&\A./IG"0MGOQQW"]YD-+\D&"=;"TMZI,$+9GL#&TA+.X 3@0)N$K=MA
M,\:99CZF#\L(_ER4^.,2_SV!<1Y7^>@K^.?P"3W-:9&,8OQ>GL4\*/R'_86
M1N%L"'X0-@"6+?Z?&:I)$3*]L8?X5)"8,HCB<9+QIAW#)'&YGJT->S^3T[WP
M9:84WM.-EZCR[FED$410=K+;V43IVPC@1[NXSZQ ^&<[X1043@I?C$0KS?#P
MXAG#@YCC2;Q 65$2(CJ#1>LL/(])I"9QF"79:6DIER0CE4H:-DQ@%#"<60'O
MAFD<*KG>.BWBF Z2=SKKGW /*FJR2"[Y3;[D09#A-)S:1TOK3760"E#:J+O#
M*B\N6<U4^?*DW'-V64 :_:>Z)-U+@5_*M-3[_\_Z>O ^B=/H=7 8GH)G>0QZ
M*<Y&..PWP<&4Q/(U#D8D]TWP&U[%\.M@?5T9H;M[OZEY>,?J5SQ6XH:KGVVG
M(>C&31AVF:=)!*,QL0#;]_=C _*&5J?><_[KQ\\X"0VF?Z-9;*SKIA"7]3KX
MK+64:A'?!">74WC_5A$.D]&;8#^<Q+S0^SDNWZ;]I2?J6_@;8Q8KD_CM$UCE
MA@4?PJW\=7T8PPF'9T]I$VW]]RM-_=#='PF_*9D\=)]N#PH'RSN].H0/_]9Y
MIF\=97#0#VY(*]V&^W%K:M7;[!N>5MB#69A=0LO2<I4V OL7]F7*B>P2/*4I
M6+BHIZ)@>.F:H)/P$@W021B!H0DFP<59GL;D1V6@/XK*\5>Z'?A%1:/W/9=&
MIX2N=_XDZR3ZJ.]AX)BB. 5?#J_\W+$/8$9A$*$5 8[+:(8S.-Q]W^V,\NDE
M6OS@C<FLXO5)" [/&KQ+_AI653@Z0]-$6_3[>25VNAYGPAX?C&X"P\W@-6Q#
MP4 \DZ?^9=ODV>AVOB2PM/RX."S2!)8&/KR6],@K6-OL!2=%&($9!M-FTV<M
M@5_BY[/99,@?MSY2PFTV <^B3,1J.J[@2V$1@:14X+&2778(0I-'Y &)"0A^
MGNTE1#T< 9N%/9AGFN87ZH'D;\)+C1\+7B]N5!DF$7M,[#.+/2G;1+\(3\'R
M.\4'N/X*^8#P 5@/D3'VL()R&H_0E8_4FH?3:0H7[S!MW!C8TXL$10:>48YQ
M<8I@%)9GL*S:(QN=Q6 ]1$5XD:&<A<%G$$-X 2Q4!6\<AMG7;F>6I7%9LGL.
MWZ=_Z E/BWP41S-XCS,\LWPC\'IC6#*,%%QO!AOP,_C@UW48>0+J!#V\AGEJ
M)[" *Q\F#.N>Y6K!\0Q,X@C^BJ,YG86XH'%,8DZV?U"!48'/,[^#7X%K$!;)
M_](9(^''Y^AW=SMFD<UK<;C5!8APB5*&$@)?0H$^53Z%G,T1Z*<B+"X;Y -=
M$NN1^(WIV66)UE6*Y[4H8NT%&_GPSKR*7.AG@R[3.@U<'WB/'&=/P,)S./:T
M&=KKUPZ&^B@^:QC')G3#QP4C(:+_DM$9RDG<,#UW D'+^,<DJ&"[@25*0H3!
MB9S_!/NLS#,8XR5(7CBJ6'CZ&%BA<61Y$)_CL8:OTFM"%+0"=_RYHS[*?N-1
M5A,@E88BUZCR2G60>8NLP8,6.P2MCYI<+5#)JVW-%]9ZEE;X8KPD9&-*UM53
M\"UQSK)#%0AB:FFW!7:,EKK;T:YK/!YC6 >^#+,%92?SS6>5%M36Y\O@O#?
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MT8G;[C76KL$@0;I.$U5DPH_UOH^[ *Z3\N9S=/FR#&[>?+P>\#!LAB(;P$'
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MV 9EZI9O+O),N\>HX!F#5[C\P4*KKZC);F;YY[NQ9W&JS @-:U/W5+U#I&M
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MW&UG<?5@G]+ 7P.18D8W'#P.EEXIJEG!>0(C8*TX.V=2N"#S80-^1\W04-[
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MEI2\MNN_Y\$"5(JB]4Y51]QAS@/%5$C\KJ3465LJ23SXFOHZVD8%;4<=3-X
M/E_6:T%='1POE:J,&7VH21JN!J!Q2YSPE8.YF.XFGT4Z3;>LQ?:C@]>*&+G
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MVY-B20M.)<RGMBN\"2>Q@M.SWR0^E2_<-!P(%?_&FG&@BF:&AY^Q\]VX,(M
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M94M+=@_YSV(VXUP>-O+(9.35:I*GQA*NV35>E(A#*)T@Y+7VI7<@@]IQ@"H
M-N(#M!&Q"[/BDXTV8%^E)#F<$9[F_!MX6*5-7Z*B-!;=MOEI,;_+&CFS3KD"
MAJ)G("7<$:-5V[3!T?YL[']C;9J/5 &B(#0Q-C+.B0B RO-)$DK'WU#E%$0&
MF-LR3F"&X490BMQ7/W'$\.HC!U.;3&';WEXBB-V@F^#QV>K0L<[VX@&^X8#*
M7+UL.@7F&?Y#4W,K1+>6:#7A,;=:K&UJSHLDUY5A<TP6*^),NN'06RU+UUT7
MFDKE7F]'XU5V@-VY6SRMCD!B^\11XQ/2<"2;ITDAH*:C>>K6_S8(:*0SNB-^
M"9M:S6)=@!8'T"G[?O9.&Z9ENNIW\\)3F,A,2E0?*2J0=,'9#=9K[;WFQ/B5
MSY(Q>L6P_)93#50KG>LWE6$_B=<OW4XDYD7CA)''N]'K$SVK$<W*:?R&U()=
MRF([]TI4(2(Y4SC8EG6,8^/N>;86K Q;OO/V:O?RR8*!!=<6=J^E(SQ!JE4R
MDSLV23J:9C0T[)1J4E%,C32[26PWN-:%SW/3[LM*+L'FV[G5-\F_7HM,CT4M
MM<*K/G5QYRN][/X:(,_2F]S6+87K8;#BP.:JO>%*Y%_IX_'/6]?U%8";VKN$
MDDF(2[N:L/*)-N^H D^9<F()E3UQLYP)/LGY(YA?3C*MZ?;6D'RTD;4E]"3_
M#>0/,7GZ:=]&>2H':$NZEP5BX"17Y/,K(-=6\U(VL=- <U,B$B+;:[A\%ND2
MUWHT+FXM+DG.CG<_QP\XW2Q9-C?O<;?3PW(?%8MT-@ZE\R2[)#'W%R2;;F;?
MM*O";6OM_99= !Q'#^H'TITI#OQ$Q39RT>%S;S.XMHGVCW*>,KX.-[R*)[KK
M9 S\-9\EDV['6JUMT[<);ZWXVLZ[EL5+:T=]3=HX$EJ;;==-\0(K(=?H#]HY
MN92X&CD#"S 26V0#TE2QZ@I/(*FHCA]N9*_,66!-BYRG:/47%+_Y]1-HX/'7
M2HYNQXB.(@;CN+#2@T7*:;G)S=\4*'1*W+.LXE"K,_X6R.E@RIHFHIAJXK%.
MB+^<YY>2)VE+/X/.% ':+#5]M\P7"DTE)N'2A!H)2O[<-I:) 1Q23]%5$ZGD
M=#4-COG<5Y_E<B3&SQLDQAJ1&#]OD!@;M_Q7JRJX:XH?"?YB2":7^:G-4;7!
MX!4SUK6N48^HB/95P0SUL^V'< 708ZZ+A*N"'MV.5='CFM(G3U:T4YT*/9(E
M1*D==E-4ABM3DG(FU1R<# \LA>OD\O_)-)3F>=Q7&7'?+]"T+[7Y5;D*5B%O
M,(G36_&#;X/*O-_E?J78K\G2Q9-VDZ:8;7XXC[/X0C1V+ZL*^SFK1"RW==Z5
M4=G;>)U?1!OL@WEE=<9QG1ECT+-G89)B\7*FS'J)(F]V5CZ:E=&E2IPR9H'X
MI?ZEAD.UM@(CY=WY<!B,"VP#1-W&[.;<:)^I0G@:^&>^M6&/=_+:)%L>=P2U
M(K\TI =T:O%+S(OVZH9Y.$X#5-3%41H0G.3"!?K">X&V?E^7-/.BG#O+OT6=
MK4*$/F4%NO_8NXWQ/H,AS3AN7<01=EAS 0+VIW;=>*JR:1?5>5[ CM$KE&0B
M9C=5Q3/QVUK@4K5O+G3.%KN'QMCJ9<PNS+RP8D5VI MU+<\A:.5K%>K?A23?
M]/:DK2+Y;L-4NT+LQ$O/ *_W:W.Z(Y*EC0[WYASE^@9RI-<!8A0*H^&'=Y7+
M/N1 VD"#&YP>&AJA@$&(!H@"K9@A"GX(X]K(LXIE-L6;_1BS'U$F1;@AI#QJ
M(E:7@"[R=)%54HLGR<P_X7K S@F.*TW@1,PF7B:L"',TEE8]G89)48M$^,A:
M ZIMBM0H(*4JR*1%DA<3X X^0 &5$EE15&#,FE!T*H8(I <6A&E)I 3-<7R&
MU8[J42;L:A?CH(\?H1T#=Q5>C[!H@N-BM#(#!2:*824WOY>=."0?$1U-W>ZH
MQ::6K>BCQKZBG_J6IZXQ#8YKA6J<J^<X=1*5!PY3&U@L9B 5V)WK3T2"-H;U
M.8I9F4\N29-;QFH(C$-#\E@* FI\[<U3+ITY-W&L1L MTOI5TT8JW*\+'Z%J
M588M#(0I# 3-9*Y[X5]2"J;,N6(ES<++_D;H%[9L,)GYM:U+*GL4J<6[VEXV
M(M ;P4"- Q%*N@&&(K7H-4!(+J 7.&]"]G_1)KYH*)EGVC=V.[IQHU6G3;@G
M%R[#-P@73QR+=UGU2ZD8C6X!D,.I>@>#'$E$U4BF$BQ0J0GBU;6**K.O7=U<
MTV6(YM,(I<4)RG3U E4M,L5[J$X<.>_Y\DG9LA*K% (U@S"A^NL/5"W2A.K"
M":") UTJ1.+@SO22/%1?C=&6"5;5"+,X7Y0@M[!HJK/1#>537<,#U!&*;B ?
MI;JK\ !U'/K;@_]N:*,J]1]<@A5-SMF9B)-WB+M1C5?J\1QG$\*W9+5P!E9^
MM\L]>@Q8MD/:-@$?.8N-C2!OQKH..GJ0W YSG[#\-^Z0*9%^HX[YNO_85\1O
M/(WREXWS?HW.^U\VSOO[:US?G._QC'V/OVDUW_)/[5PI8<&F]8E;J+VY$+DP
M6E4^^EU8?(PK5_(@=[4Q^LSJV;I&%:X6<08)O)!2R6@^!!.1.)[[295&X=:;
M.#'5)D$D"(Y+'V2?/MFBH,JC?!!#:YR'6(0$'F1\;5ZS2C=>I#]-Z%^K).)3
M71+QU#+0A8@V)1'O+I.2DHCJ5$% IH*.=)B2WVR%F($QSJUR1&EX66J+3/>R
M]/K?*._Y4^S(P&8$PSN%_[D0&?WTUK;B&+I4R%!A'[W^GBH#1\Q:@PR[!E^O
MG%[HMQ"0+ _19W-8[Y/TVN"FP6P=H3MKH,PX:2Q:A_A4LD+LQSDG;]U4%W6S
M @F"]<.2S6<9-[TXXV6ZS40,"M2T)?6_Z3K0Q(Z;KM*[E"6'6WZ?YD&V$)!S
MD<6, IHNL)2FVY24>HEZ?4BM I3:7:2@]>)B48\+T$M@<GI'0_1D)%-M0:K4
M1VZ0VF2)R8)HGLKD#8,,+HG:(5C-!^7V:&B!RWL;QW0LZA\E-VS5MV"@NC>P
ME2P5"5513^O?98.Q:^%0T?-I)749B!67-T)[V<PI]U<B.%=MX+6TC4%SO<S5
M6B+E1*F5*]21+.HM!?<_3;&RX$%>(?FI\#C=&@1PGZE>6@8C"*=97#5D]TO&
MLMU<:7Y^5:(]@+:@/FYG4F[=^&"1I>B+-&-S;JI:E0=DS(!($7ZL,>0M=0=6
M^[9&K ,#"GI/G+8>QCGK^LBL3PD=(J^TKR[=2N]+_&N_.89:#WL"=()',C65
MW=4^4*%V"VZNFE4-5)5ZD\Q+X&BDIW/3Y%K<H"IUSP\C*BYZ'E*B@$N.#*?8
M: =W4SN0*HH'YD!U^U*+$'7W;W;$<0[[F+S%G']+XDKS5V+[TO(MM#HG*-$8
MH@U=8A=S+1J=+C_M(E Y_(F[7NF&2]REG'B_S80U&[#HM=YC'*0+\Y(5A>%2
MM<GH/6%_8'6[T@+2Z1U!(:(+2TBHLJ4DAJP,LK7(/"^](FY\3L(!?-+6-)H[
M;SEN7(2LF>\QR@KEORR]M-,YK;[TD2K/$NR3^-O3+D>[ JY=)3:@-N<H1Y2+
MU:)5XXB\#AVA$]J,3U;:IF^8V9UD9E+6RH]-MO5C+E3LTDV@).ZEFH'S=4"W
MNS1D\8J<\U4**QU%[!'*P*2E-4W&)'@V:*(2GE+UB9AQ4CH"%Z#-Z4]W/<A.
MT"_#.EX1JV(B:H6Q'J]FK+!N%8XI/!US+1C]U7J$U&E<+8^I>))7"L:PT@%?
M7W(H86R?.+L"EP[PXP1UFE0+ GO8D0BE7FZNY-V\DI'K?8!KP%V:#-!9BHZ0
M?S(QUZ#=OJ[C6%P)VY@1K7XK:GO-"E+5E1*B3:QJ8MT=%RQH1<<<+X*!U"FH
M=HSJ@'*;J#:4]$L"5&C?"K[H%7P>8Z)6^?&*O2T8DJ=NSG!VNH4MJE!IK)5S
M!)O,I-(>-LAZD$\?T .%M>6DNHD#F*.B:#GHL*BRU>JEL8\7,-+VTZ=U9[2\
MPJ:R\0<)O">_-%4$=>T2OV0;I0W*;^.&E/:FCI.D>%VUY=4J->RGK5_:'4HW
MQ%-N["Y^01CR;YLPY!K#D'_;A"$W,O:KY1 =QX[)[>3W&Q58)>'+K[EDD?89
MY51U5,9AD]K 6ZF0 P&N3*V)FI%FE2NI%;6DG@&JA*MM@/H&6;W"")<J07L<
M-%2=RHWS0\DM7H*+!/:,FJ&S6\MHI%S6!9>5IEH@>5]7X<ZPJ#3R"72-BR1/
M'5RL)]/EM27RO-L!(3Y0AJF331YR]WFM:9"%C(B].&K5(C:J\*T-HOZD@ZCO
MDA(]Z8P-VX1/[RYS#55^F6HN <KHB<'=!^^I=J8"4X#,QS8R5<7=69%_[(;E
M>8-+-<ICQ@<+FL_6A\5G>)$3XY(L@&XGTOWL=+FI0L\IM+,!_&0 !W+MF^]A
M2^CV<2_J@R$TL#QJ&LG7[32^\F0K^&!'7)6#5D&/IZ;;O=4>RN?#F2F4A:A:
M"@!I.:"*'W L&5T</(@8"#I*R%6%@)5R0;>&-C^E6B&-Q7^_8)^,[BA-$LO>
M22^>E<$NX%=I/RJJNM+>9'O# >XD!Y 0R=N\A(= A9J"1;J'-O5BHF*_[T#%
M,$J"#9IQW'23'(C*Z%+*T1@GL&&>7S&?ZGI&5BD5+(OA5G<RM7Q3FE_%\XO<
M^<V<^3GN#U%?. ]I@G828=)5B1Q3@\2]I0-=K$NU7;.^+YVHU0P&5' 4CF>6
M2?=*5<QI6=VJI-)-*KT&;]9L!BH?T^Y4R5'QLA+$ 5W;/(ND!HJ'WL ?2=A;
M;Y"C'>)T_<VA(*QL*@:0*CNSC'B&=#M8$IFI[SAN8O(187P4],\B"8UPPH/4
MT3<SI7U)DWCA3YF+4_K#;]C/W60_$M0X":M%@?E3\"36'L*_O*&$$?Q;7$V<
MSK:4SH5$-)_GV'T>2>E*^_,KC<8ART6S"=8.YDFA;X+.0M12CXB+$B4%4Y1D
MK@LUM&$2*F6-LXGY0Q+[Y"2L7%)3^",UL(+ AS+8856_"4>6+W0[\(D-7=]-
MNI;(P% E4$8B63;&TC?*-M]>[WF>VC+0U70&#0E)MDI1:R4DBC?Z:PK0[2GZ
M25@,0RP<2A&4@5OQ&Z&$&J18*QF#*#3.*-/\T&UE4S-(-(K1UNS)K%(A!;%O
MZD7/MKH=6P&<+@HRVSQ%,!&\1%,['973JW/="!*F=J(25:D4)$V!99QS@KC
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M[B3\!H]?A K8+SPT*]3/(U;*=4WKY7,_CKVY?QG2)Q:AGT3)1>Y=P$V?L+'
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MO3;^N>$+65^5/ 'E.(OD,DNODK#:/8*UG11"M;7THW=AU ;NC25!,TSQ/7F
MY'U>IH5*)FO]=BF\N6D\'*2JW(<'V^N6/T.ZN&F:^6<-))G'7Q">*A29WA$6
MJ(=R+87R*S0=HJDD@BB^%V:$L9:X)N5GG8[EXPI HE); ]:'<OS!N$_":NF-
M*D3#B%+*=D';[9E)@>1U4@0<>ZA-#U'BLS"3&]X07W$S"X^ZQ22JZE*5LC1;
M:(0FIFR!]7X)!.*SZ-T'W6;><%#? !>ZKX.X7\6 -_*H,K&Q=V7.%36&K,-6
M$%1+V/*U2F10/X7V3I5*_N)GGT.B7C<T<K8FPU 1A;3B2/47AU%D=I'&VQ%;
M6XZTV:8Y!RZ[$NN6)47\:#QF5P"MND1KMS@66-USO5N@#R<@A:H[R$QOCT(#
M6$^OVHMZB$[N/7>*QY08M/$NC*1:<0G&,PU=B\\:B7/D3'_;2:3A%-K>BJ1>
M^%Y0/7!6+HCO4/K.AVYR4+U'ZN]NO')<HE9AR0%!X( ?9LYRN+ZXOZ@;Z,W1
M=,^I"$LH'_4G=?%/X[$S.(6/<B=B[]$H<>[0^JY:,!6,#9:+A6.24VY3K/Q:
M,LA5G=2R1Y5VMK1[92JF7%?.2=UDA.525/Z#OJ"MS<LLJ_&>;6K 3=(V'-CB
M1C%J/_:SJ&'!:XR?^*9TA7LCUPX*9QQ><&VJ*#;\V;244\ Y7GJDSF@E28EY
M#A_&9;SOQINN<VU0,PF0K<.U2I-JY\%0^?E67^7AP+A@N,G=W05J>XP_SM+/
M?$WFL+S8J330^EI32>H&!!J6YZ3!K7Y)7'1)OSLW^^V]4\C9,3V/EYZ63A<F
M!FE>Z%M*?.<],_VZ ]'_V0>B-QB(_L\^$-T'HO?-^7K.SM<)O&"1:!.O[TRP
MC=$=I*NO[U7%XF./N9;.'E=;?W-<NUJ[7>EY+F]B7 W":;RYGRUBJC5UJ<09
MTT_VT=BF0U^$&">"OV#C\H3^YE_PM<UV@NT'Z!]=S5,N$>#Z@-"ECG3R%I37
MQU# $LO3K= Y)=J7<3B]"!6*9N9',4$'4F6U29K EZW&I'I<#66-QL*(SB&P
MZ664IU4KD F#+%"-LLO9$_1F91(P"PKR[X*E=8G9>_")TU@8$J3N"!>9_'ON
M%U90Z51MZSRZE!6*@CXF<QP.A"0??S;2-5YL!"W&_"]Y%ZZRA,CJ<+Z#.N^[
M#2IY_+R%'A0;7RIOX\DC]2$[HS32EFZWQ-@8KKK\5*SPCN5',IX[6W^O<?F9
MF%#6FF(NJCY-=94HXYA@+A40*&%B31PA]J_&GF:U]2]\Y,ERT.MQFI,K&\1^
MM,"%]1>P7O 7Y9 B_S$.!4WC=1ZXE8+TP1K,DG"52YB'3.V1ZZ8<H.7!>;$8
MO&+#M_Z>!F63JF.6"[U ]FO@7UF4DX25A<3N;()>9+:RZ#[8EPPO8'FN0P!B
MR'B[B#&YAJB.O",MP?ARZS<"I%G7BL-\<IE)__=L93V*BO+=N1/CB\-.C$)E
MDR')U,W/ZE/>'*$)R@C[WWXC6*REU.IK65!&%1P=K0:2Z^-K+Z,TUN4@:AG,
M#^M,24W9WZHV<NA[;.>8SII2JIA;9ZE4F76>J_3Z:?'+*Q%I"B)8S8(L_)AU
MZ3:YP\2["FN1Q*OJ+R@)@A%>4D75\Y +?%*<;PQ,<^-O<.80,5\NJ5JEB6_:
MO@SL M'A0 4A*RFC2G8'U +<Q%0O"V,0JG6&69IN.J+ON*DYA\#LL<04YG/[
M1ZNNQL-!I9^TYIIC"F=A<"ZR"-9N?;;[BF(@R"473I5:D_%3E])+UA]J[NYD
MP1JJS;:3A;>AW<DU5<I!A. ^' *)#UR2J:D$4FM"M'%ZV-P(X\B3)W#X$@&0
M3+$UTLP@M:->@XJ;]N(4?P-_V44RZ*L?0:<4@'V(4<RQ!FI6A$3>4A;8)@/N
M@6FHH-0JBL/@F,04.=NEG[J24U>Y^KF"STX=*;'W3B-';;1$?K-1J%VNIS3=
M=E%"XV8*T\W$\=='TTO%,*1CEV89O>^P[K2YK4Z5L%.C6A2CGO 127P62=>8
M$!"NXJR9DT[?1&1AL$@VJ;6;A%WA)4Y:1??+\:] &1UZ9WSHR<\H5KH7#W;?
MQ=>C781K'7#,GI'VHJ1B1=Q'86Z[91$E>B8K[GX#IP4>.M/6FG)JB&V44\KL
M90A*.;O$C=?SG"DI;<WV"7NG&V=LZ$=O[>K\]JJ)MQ44^T,?B]Q@+/*'/A;9
MQR+W,<8U:8UQB6+E^);=3TSB6SGR^I%_KYHO_I%&21&O.N-8;B(7+703BL#B
M,!6@: HZ=$13[-ON:R,I^*YUH92QCJ58$93:J#%?KR,EZAZL1R/RM>$(IN=>
M&X^ >_2]Q"%\D[VL5KK6??Z::_*BV>W'2JR;^OW6_5TG<5XYF.1K&^/DG=[4
MP:\&-_Z\?S\<?'W-VVWX]UV%<E4'GUS7NJ_KM;JZC6ZN[>6B*:^WGNJ6J[R=
M3H?#5I^NZMZZ'IZA 5[3^$=[J^ZBDK]UXWFO]XZU-VQ_5.?2T7MG3;.F :)B
MYKTMGQKL_[5.=4,$H8M4N=,Q]EK]XN&@W3'^$WYZ&W9"XX+X6+MX7&KP>D'\
MV/R>A51*2Z>;*5I3F?JQ+FM.N6G001(6"ARD8[)+/ZKA;ELJ RADK%4353$Z
MM8W/]5UC!D 5!1QB=EZ!ZVP<9RH.M776TE]Q73+&E_6-U'"J0</*L1Z9WG25
MZ92JKOT:/%(VY;?]L8HL"3%4AH.7\X6:Q+5)3"AO#YVY/3 E S8EWTJ+8Q",
MJE5IT?&S67E2"XD82# 55W.XF$(HH9N $2O0+AG680T+4X6)*BLS<F*"$>#=
M9<7*39*0F-<^(X/2$1\K&B2C(),,#-*%%5K!H$O.<SC C]8'L2)3L#H*AZ%)
M:8#Z5V10!,>GP!>9!VC?Y%B S?HKG*%6DN0"EG/9+(NA&*G*GE-P2PL:R\54
M/MJY^I:L+X\:)&@9;1LV(<A- JI))<I@/3W6.N^2RB>+(JR/!(9X@=$DFTW<
MD#1ES++.5W+#BC:D#$#ZK$2>@R]OR2-08A2MBE%3S#TJM(0SBR?Z3XK375'R
MP$9DLB.+94A?=GBBI/;<I8(7.B>K$R/<NR'#(\'Z*IAY FV#D67@R(HJ*#Y)
MDS)]Q;,3&A"F^_D#A"<(VV2RA[!LF4Z^4<3P\:,^9+C!D.'C1WW,L(\9;H-2
M^7[#6N4(O-HV(ZENC["1 9X74<6%VLRPB0/MG%@B'@M*6+3$;^C6)Q4#@7+T
MS0A^$W3CEVFS4K5 ,(4!+38?-C?!,1!\ B.7+P@6TWSQ(2E/K@J)[,PGNUY\
MU58'.2:@Q7KK#N_H<&K,ST8;3\V$XAZ5M90=N(9]U[(6S5O%'2Z>\A20IF[*
MNT8Q$H;W5#?WP*$?\"+L*NY/S1='RF&$:T61$+;;F_5E8X-93531?+7)JK40
MTH"'+2,K^H<4[G'$WHQNH0.F5AQ]#GDKJ"^0*C2B%G+J]12#(S);(3\4MMB;
M3(C"A4)IZ.=<T=3R$(?%JN%)-M6"LD7#F/J2=YS2^GEI6_E.04;3M*8:*#E>
ME6,YW7I-+$Q<XS%/4F^1,CT5MV6L3:'C[%?'#*<'!RT8@,[93#BV9-7AY&%1
MQ"8ZWB#^G$Z''5/@/W0W<%/ QE<TJ\)@*6Q2.I8EKRP32VCQ*7.X()F7+O97
MX?30 ^.C;=P&=,AQ+(1-5-Y>711*VLL&"QB@>:JJ28XUVR@Q/= 4*J'9;4-2
M?5(!\!96MKQTUFM$+R"0 1E5-+,'-5K#E@M=NIPS)HC6--' 1"";<N0S"=B+
M^P0*H# ]KJU9]2[.MEDC0LXO\=,.=GY'Y;=HD^;KPKJV.A^@+ASQ^+NB'1:
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M-L)S/814**+IA'90T& -ALM?335JJI48* )KE96L:"70H0 $KV@UWO)5H8+
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M^2=\-K')#GL6P5Q8%,6(H#S9! .5!1-*Z]\(984OU0YV5SO3N^^Z\@ ")!)
M90D@S,N2&^2QN8@P!)U[8/('%(J*\12ITHN".JB@"XJ\GI>6W6P$@:["&TF
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M&V#\%GAT8.5PZ(N:FL%=\E'?)6/=L<R7OF@)C3-8V;$P:J>%*0M\2<Y-&+T
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M;W=U/OQK1MP(JA'ITM+/_&I[9VLO6R>O<K_1-MCN;^5=W@%>'OJV8,(#Y<[
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M^P>X/ <90;)J&@HV*8Y2XL^CJ2Z2(L7/8,").D_RJ7FQK%2X;##]J:YFLCI
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M,))!N19QB(P +ROJ*=?!9+H6*)I8+LV<'(JZ,']Q+9E48X7>10*4H*/;>82
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M7 \!J0/AV@ #_JFE<X-!7:CFI2# 2HJ/P<$GE[9 DV+$_$)G+=6^U$.XDP-
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MP-91MT&$PMQ. @]L_6Z9)E ^'GV \RRM-&=['LRH^6*G*K/CQ>WW(=B.*)7
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M>5]"!2V90#AX&#[6-7S1UYE#!. L59NT.H?)M9GM'$Y62)O-G\N&A;2T.1!
MGSON/G59(X(^&"=Z-]L+2&5!G^#-#$CQV8-G_O(EEM0S=;F>P%RSBSABE'L.
M:_A,N U-@J&"5XGQ<:STP24_+QK?1UZT>>0$D="8G00X'#9N;D&QIR!VZEI.
M]/;!N,^"ES)F;,9]9EHCW;QCSCO78W;2E&&#UW'T9Y?19[V(TR3+^S)OMP!]
M&XJB[-H/E:P[!.DL1PU]8&X3%=B#.3MD1)V!;N9<R]XF,$3XH&>YKC42SS*-
M76Y3,SY?KD]'N@%B^8X915NN_\LD@)G&?WXK;19W=@LX()@L=N.E,9%3QK3>
MF6>PW"D="(4?5SUC77.'"$[QCTSB1<]R8"_D1'L&5:])!2#FEJ%K.\1_&4PJ
MWY>B]_$5B2\(;JO_,P9<(0'=>]]U":2 +OI_&H)/!/N66(5>X^*X<][>5[KG
MS?-V=[?0:RPM)MUVZ^*L<]YI=Y7F\3YI7[8^-8\_MDGKY//G3K?;.3E>2O3*
M/GI?*1_JYL"US*RRGV_E2;E8K=27$J6WP#<')V>?%3DBF@/H2]2+;>$LY7+[
MENJAH8U.Z94:.G*12_?OUK<M;XL7SZQB&89[I,5=CUO<\3DSC:W<X:R%'2[U
MBF)>'G:@&)!.9^WC<^6L?7IR=K[:AE^T#:>>PSUJNHIK03,58W:DM$$LAY2J
M:]HZL?K$'3)\Y3FZJ\/P[8DZI":8*4W5Q=>E^D9EM7V_ G;T.Q78 8?9EN.2
M-0W^QAUA%+P,QEW";F!._S73UK?)K(2NS$CH4^&UMJ5+FRZJB_]\X[4#NZ;5
M!@\2U3(D_"&C3]QM!'0$;8<:G4X!6F8F17FIF";*$\!E&G][QI242EF"LRR4
M[LNXKTM*DX$MD!A,S*8QU7)$/F";>"8X39@M"&:-J+'J4Z.,EIVQ@<XQF^!B
MH#*=&"U]?/JIMLFNF]\?;3?@W[.1NN3<F<:73OOK7N=2Z1RW\G>1VK)*PK7V
M!%9$0811B$1+0"@G79NI&'K3B X[YG+2&E*0*<[Z<N*ZI!PF8&]9HY'.,<^J
M'.@&(\=6?EZP;R18"=L!N?:8D\Y&_-L&FU[\N"[UAX]GH_(\&T7S8CRWE*N4
M-[=*;UY4N[0'VZ(RPX"G*B; ,Z#/\&^;:EKP]X/QBP6I=DB/JM<#QP)AFE,M
MPW*VR7BHNRP,2L%#@]H<X Q^$W'97==Y^,0WS'%UE1K!*LK(D1_GW76UF6!9
M$%CJI<7#'H1JI?['LUO ,WQ33/!-QP2]9?NJJ^N"V=&2N=Z6I2W02%^,[NB+
M5?IX=GS]6/,(L^R8BG"9[5@WR%-S]M'&/*_="BO8BLR@8["T[N(^5YO;UP?O
M6_G9MVV&[5* ?@O$V$X0XSF==/P,F"HV^3:)?G#]K;DY'%Y\_*0^7J*GI# 7
M )%I;&[EBL6MXF;Q3OD.FP4_G&<71S\3-G]2NTHPHX .S*H$FZX_#=O]:EY[
M+9"N=?)G^6Y>@-<>V88U90Y)DBM:2^NII%@0:KNQ,CU6IL>OD?9)D[VI:0[C
MW/_G"/SE4KJD+SF#T_[QUPO#UA\OZ:OSDCX%@$QC0RS\)VJRH<6'S"5==X&X
MS\ZY),4[\"NGXW?9;EW7AM?CR8 ]'K_-^^!7SC3V/-U -B%[65)SAZ1O6)9S
M;PRWTC!LP:\GSKDU-M/Q8ZVF=6HT2]_.?R*$45N(7S1]IG'.#-*\T6_NC5 S
M%2%I5J9C,VH;[."H^F_5K/^4^>O75*8:OUN+D96],HT.=R@S5K;NDDN_4PO<
M(..;;B_VMWY\U?<\M]_<J-0>SS[UA125@ "LW'JM5-S<6IFX,X:7OUJ!D1O%
M#O_SVU:Y5-OAY*0/)AA;&;Q/N^[?.J<"-J3.-VS6+@OL\W2O@,YE]M R&9&>
M<I;HIFIXPLB@#J,@I#0V'[]M^>(0U7<3FBT6@'3*/GOCPZ_?]GN/%H#E1+XM
M/F>F\5>]-E>=[._.'-3[/M1'%@BO4\3ZMAA%UW(_6V?FX<>#Q\<HRHGDS>R\
MF48]5ZM5<J5J<94A?!SLWST.WO/T21,80Z9>*UA50&W;L6Q'Q[QUSYJ0'C.L
M,=%ER<$!F(1D*W=(^KJ!W*)S8!V7F1K3B&L1KH\\PP5/Q/*X,24<W'O>GXJ>
M?@>K!RA(K]^O8G"BG)9(0RK4G ;O^N"L6F/LAU%7'?,KG*QQQLA'9C*'&J1C
M0E]/ED@T\^6\!'=]>TFWX3W&#US+_ADKRL>CF"]7=?,YK>' D_SJZ"Z0/*;\
M/-,/8?$%$=_VZ8A.U/+$[#^Z+J-G60:CIC@*,R-G$]F]5+"0HNJU2F7G6=VN
M9V8*'S,!GYI C]A^I10*'ZS5)I5R58J1V0HI+(Q:*]5(Z^",E#>*>6B8;IS]
M<I)>!K/Y^47?F]V26;&RYXN5KF7H*M"J.?@,JA?TKY$N4\KMD?;1Y=/FY<,L
MM'O*E$06<QZF-R%0(K0$B",?MWEI4JK07*D<$RB).LM0G%2*>=ER)5%>TS:_
M5XD2E.R=.@RM 3Q"*JKNT4QW3OK]1;Y?7:UIIZ?M+Y.A\1R2)9&Y7@S;FY P
M@%Y.C>%W+]NE5-%RY;7>^OWDC6R[DCBO:=O?J\2II4N<#N<><^Z4.T?M]HVF
M7]OGA]ISR)WJ+7)G#L)W+'TV6*ZRIMY/^OAM?TEX^X7"+DL#?.3D*C*6QARF
M)?8W/$,DM(L?6X,]747)EB=*]F)5-AM;SY]G[C7.\;*D(#7)J#HDJD$Y3YS4
M6)4"+*+&E]DBAVJ!B]R=CGJ6L<;75QMT.U(H#W(H@1C>F31VJ!T5<!1?8M?P
MJ%""KUB@Q$$! 'CP)-(2L[OY$];JZRV$."XTEZ%N8'DJ'%8+^KP+NC*D?PWP
M'5-#]X@IO2E1,1^.<%R#T&1@+SNSR6J=$Y@7_"L$=4# +AR[0_2R;$Q@4TXT
MUM=->3A3IJ:*U923^]&!_0VRALM7VY'YJ6)5$:UA'A#@-I[KQ!L I*]6[N7*
M][P&(!H5';>H8VS<_))NV%)36]NG'&6&<F9C*^5$$6;0ZZ/HU))]%IS#_KQY
M5+D<33^-GR7YG%*^G0K<O2,JR[5]2TU[G;ZR6'9A-9P4A"0I"/6Y@ITAB#EF
M,-4%,6=:(M;@<29: 0)^61#>/:R+^(.\?Q$)3,QE3)'\QSI,C81O OCPQF$W
M.H=^(#RIJ6):CJJB\APAQ8N?->IH7!8$:8L"'1MK- QTQ(5BGH3$N)0;M]14
MEP3[B>\ C+EKJ7< QNX(C /V,G< OAIB22P[XK0#O7]X&"B&7@)!82//+_7"
M&Q5GKB[<%#L=1>/BT;?9Z%QRAOGHV4SX;9Z@(C<U)5627%^#]44/+96V@J4*
MK._ ]/;O^YQ;$X?1ZUR/@20#8&RQCO$['>4BA(02V_YH*CLQ>)S@GH'65M'7
MUU&C6*OJYO/+V5ZCX[*1 +>4Q\/?3Q.S>V(8VW@L3,"BFZ"[*0EJC,@^>DY@
M,MR SAXX3.2P\@MC52_C)2^DOZ56[_Y#,/@8#E[,"_I\ 4R7!$?_U6_E4KE:
MKF<:)Z:2N.(L2WQ$ONALW-,G>)5 GMPZQ!K:I'@4I5S<\5TD\5=I9YV(R)((
M&0B&X)%G#U8N6+%@6]. (93X0*?!ZY!?PC&%?:V"/*.ZB:8TC*^[8HX;QEW+
M2::"98081VX%D0P<45;W@S@'2QVZ8M8<XQH4S'#]!D,F-I@%8EZ2 $N^):?A
M6Y%D!WT0@@<+10<PQ<"_)V^KLI6M;6X0_T,&MX\F;S</Q[+Z2@SR\)@;9KXM
MW ]+O<Z"MG;(#34 @=^+>3QHB&Z)G([,[ WVZF*O8 ;H[;!<WQ..S9@ZZ 3-
MPLAR!^*]\M5_'X('2QANHV?CG[5:%A@^P!6PCT\JEMJ'/9QK?HS9!:P#5=;+
MP0(JLX.FH#@#J)C7M08RZB7(!_M$F(4=LB0VV"RZ64)=!,[R=UP!4E$%A+]7
M\EN;8M47[*B @')NJ7@*12-)..7;:&"2&+A:K_M#SX([,ZJ2'#41 WN] FEY
MA.Y*73XAIN=#IJ0P(' GB.0>R.+1",0ZD#7H)C9ACJIS89%+%O2?L!BGS(D^
M9 XQ&L9QV,36X1D&78RP-ZH,I>\91IZ<2RD;%QYW@N+9T!HU!WZZ:S%@E7RM
M$H&5)=SK?6>JT$U4PVT0NH]RT$8N1I*D='*8#HL8XN##WT<+4G ]&5*C3_!:
M4T[ZCC42@BL$!J\^34=J1*>(4[0$%BH]E?*A@4>K>Y3C";B^! %3 J9%&,@E
M51BO0:1,Q*3$Y6$C>?>KS+^B[$(X%HA_>2GG-&@U ]I+QNQ_&=F_'P;OF(IJ
MF:8?OXR4[IQ=ETT89S,&8X+@''TP!!(.#<:$ZC^+MSR3+>=L1QF;%54$@;68
M)Z<Q:Q$'O'6D)+3 'PY^$\V1]F0?;\I$H#DU%C(+ JVD =T-FB0MW9F,&')_
M& ".;NE,K$6WW8K;: %[BCBU#YPKY&^Z^2GMI<5\+,1,* %#D>='IV/RTQV"
M2=VW/,=E#" L5=8Q>"Y.I6MTROT>"@>"E<_<<)1Y.DEBZ'?!2YIC]IFP\T T
M@JCB'FQR^OH2C:D&Q3V+))L$%D"9N%.RMEE<!YEH, S-2U!IWPV.X,6F1I=!
MY ;$%=ASQ!/-* 2I*U(!; P3]^098MBH+*8(8$"&\]9C\RJQ)7KTI"D3KN3L
MF\)4&%+SS!*P\*W"3&1-T8MV&+B!')Z(=C";[Y[I.#/B-#*CR^UP:$NX4K$S
M["HL \#K3!44,B)%1E59F!TDYTWJ>@Y;D=^;PA3)+PRL&-R:5> &<U%PINOL
M2/$T!_)G:JRGB31,6M3676J *G+L?!;K4:(0#1W,Q8^20T<Z0A,.^$S,*SU@
M- M>/'#DH"'.1;-9,) !@*=2K9^%X:/06I\)4=ETF@Z+L-EC<_<9:(0?'BP0
MAF'RQ3\47W4  7"1759A2-0(*@.%IP5:9#%(@M%_KQ:SX%CYI@/EEBDTO\$&
M,!/,*8T%3><]6$+1GXNV"9B5< _\\)5G<@9>5P>$B::)5'IR#](P7F""14M%
M>[HF,_Q^;#"423++#HQB& K(.1=\,RF:$%(:9/&EG')0#V^ 'A;J-[JO ^<T
M,)X?J&35L+BX *1_GW7$)L*^<8?456Y7VBGFR4I]OU%,FT&D4YGA4Y\+0D\#
ME32WF2R#NXO@'/3P;5G& @/U_$MP)OI(AC%^K^2K!  V!.?)M"^0G8;WSI@#
M1? U2![!Z@O8,;("PK E3@F,'77UJ=;' ?A]QD.0<$;!&"G3T&?P@%.%T3"V
M/$-#U#W#%0'Z2&2   (\*@$>N"[)-90R]99U0A;&FG%!9LK3;2H (Q5,12J8
M%<^^*4S/;_&=LTD*E\PGTDOWU;CW#Z %LRC(1STFE5%?6%\X$+>,9#&9C$^.
M;*%QPJ!A,L0BHQE2C\MSDT$)6F6-KJ^5T[[5)6MS%:SX%789'<E"N83#GF@>
MF&.20Z/$G?#<0V<$A1=H2YQN*F1%6K(O*\TP;,:<D:(GRY39P#,D9OO"T48#
M*?C"#!"1Z_F"I.=-&<R?4N1<JE36FNN NPPO" BIZL=\1) AEM3T+1_=4:RQ
M&93Y1?U,V /<LH&_P-!:K+$P3V#[?(,$Q+V&6Z+W!'@R%FOUY6*)'9;[BW&<
M\%XQV$9+%!1&T.A<D50QHIJ,<%B>*X;'BE@A+_U+Q[B\/T2N%(*@B7H1+@S3
M8[Q7<*'2N0_9*[>3?186QGD$W<M%[6%L*79.=-%E20KB9=N J-!-(B 77RV#
MCD%C-&'/'-P+8YJ=VUX,GF,8I\="1H-!!9_YO'UA"NH4YAS'DTH,Q%>,!T65
MZEWA=$$#<5@?Q+7I_"D(!M&)AE72EV"54UL&K!:6GL[60)97-9!OM0;R7?'4
M+[/U0(NV/,=!P7PF/X$)$C>\-A0TEI]B5BW?HF!A+4=88Q2HM[B:11WI387J
MDX/(E"OZ:N8TH=PC":T(#VCJ*R_H^1U><$V&,U 'R>"5$/0"@NR<:A<#2Z^J
MAPEQD/G@;6&^VG*B9)$3MO<M)C_V*R\T30(EU ;"*B 3*C,-O)43]*8P12<H
MLCHUQE5'MV,!_\6IWH5U5S,% =E[)## K%%N#18*OT&RY\@VF,ND&8]/X[Z
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M\HEJ5-LMZ*]4^+Q]*L(O(=Y*1[\"*$D< A*?0%;$\2N@$M^??774T1KJK"\
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MW:(!&6VSH:L"@@.P!M!1J=%B/O,YDRSQ;AX+4).'I'P>O(<24.\6EA[;;68
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M3=?BD]BL-HF_5C@C8LM_ 5!+ P04    "  <@>Y:U@,N$EL'  #45P  %0
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M[[J[9'35-&(;Z;;]LKT5M@_:72BJJ4@RJW=FPT$'Z#HQNQ.-BB[8:JH;V-;
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ML\&^GS;_QOZR[V U6WX"4$L! A0#%     @ '('N6@['! =$HP  J" $  H
M             ( !     &5X,3 M,2YH=&U02P$"% ,4    "  <@>Y:3,$M
MJ<1#  #^OP$ "@              @ %LHP  97@Q,"TR+FAT;5!+ 0(4 Q0
M   ( !R![EHH+47*[D$  $NU 0 *              "  5CG  !E>#$P+3,N
M:'1M4$L! A0#%     @ '('N6JO,)EW75   @+@"  H              ( !
M;BD! &5X,3 M-"YH=&U02P$"% ,4    "  <@>Y:(#W*1KPU   I5 $ "@
M            @ %M?@$ 97@Q,"TU+FAT;5!+ 0(4 Q0    ( !R![EKH)RDA
M>!H  (_)   +              "  5&T 0!F;W)M."UK+FAT;5!+ 0(4 Q0
M   ( !R![EJ1<.#W*P,  .(+   1              "  ?+. 0!V8FEX+3(P
M,C4P-S$Q+GAS9%!+ 0(4 Q0    ( !R![EI=%]_G_0H  '^&   5
M      "  4S2 0!V8FEX+3(P,C4P-S$Q7VQA8BYX;6Q02P$"% ,4    "  <
M@>Y:U@,N$EL'  #45P  %0              @ %\W0$ =F)I>"TR,#(U,#<Q
?,5]P<F4N>&UL4$L%!@     )  D %@(   KE 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vbix-20250711.xsd" xlink:type="simple"/>
    <context id="AsOf2025-07-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
        </entity>
        <period>
            <startDate>2025-07-11</startDate>
            <endDate>2025-07-11</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-07-11" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-07-11" id="Fact000004">0000797542</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-07-11" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-07-11" id="Fact000010">2025-07-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-07-11" id="Fact000011">VIEWBIX INC.</dei:EntityRegistrantName>
    <dei:EntityFileNumber contextRef="AsOf2025-07-11" id="Fact000012">001-42681</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-07-11" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-07-11" id="Fact000014">68-0080601</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-07-11" id="Fact000015">3     Hanehoshet St</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-07-11" id="Fact000016">Building B, 7th floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-07-11" id="Fact000017">Tel Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="AsOf2025-07-11" id="Fact000018">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-07-11" id="Fact000019">6971068</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-07-11" id="Fact000020">+972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-07-11" id="Fact000021">9-774-1505</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-07-11" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-07-11" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-07-11" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-07-11" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-07-11" id="Fact000026">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
